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ABSTRACT 
 
CROSS-COUPLING REACTIONS: 
SYNTHESIS AND PHOTOACTIVITY 
OF 
ENEDIYNES 
 
Melissa Quance                  Supervisor:                                                                                                                         
Lakehead University                                                                                                 Dr. C. Gottardo                           
 The syntheses of a number of photoactive enediynes using the Sonogashira Coupling 
reaction are described. Alkynes with different characteristics were coupled to 2-
bromoiodobenzene to yield the desired drugs. The enediyne’s functionality and their ability to 
undergo the Bergman Cyclization reaction is of interest given that a variety of naturally 
occurring and few synthetically produced compounds containing this unit demonstrate the ability 
to cleave DNA. The compounds were tested against human alveolar type 11-epithelial A549 
cancer cells and the non-cancer cell line H9c2 and it was found that in the presence of light, they 
showed an enhanced ability to increase cell death. The enediyne with electron withdrawing 
functionality resulted in the greatest increase in cell death. 
In addition, an independent study on the direct arylation of heteroaromatic arenes with 
benzene was undertaken. In this study, substituted furans were treated under palladium-catalyzed 
conditions in the presence of benzene to synthesize biaryl compounds from unactivated starting 
materials. The presence of the electron with drawing aldehyde resulted in best yield of cross-
coupling product.  
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CHAPTER ONE: A SYNTHETIC AND MECHANISTIC REVIEW OF ENEDIYNE 
CHEMISTRY 
 
1.1 Introduction 
Enediyne chemistry has become of more interest to researchers ever since these 
compounds were isolated from bacteria in the 1960s. This interest is due to their potential as 
anticancer agents. Their three unique characteristics grant enediynes the capability to impart 
biological activity and have displayed great cancer fighting characteristics. The behaviour of 
these compounds can be controlled in vivo by synthetically modifying the different functionality 
found around the enediyne core.
1 
Currently, scientists have been experimenting with diverse 
synthetic analogs of enediynes so that their mode of action can be better understood and 
therefore demonstrate better control of activity. Although the exploration continues, few 
enediynes have been FDA approved for use as anticancer agents.  
Herein, previously synthesized anticancer agents will be discussed, along with the 
synthetic approach and cycloaromatization reactions demonstrated for these compounds. A 
closer look at enediynes that are thermally stable under biological conditions and still exhibit 
anticancer activity will also be reviewed.  
 
 1.2 Enediyne Anticancer Agents 
 Enediynes are a bacterial natural product that consists of aromatic rings and triple bonds, 
separated by a double bond. They are unique due to the three different sections in their structure  
that impart biological activity. An enediyne’s functionality, delivery system and triggering 
system can all be modified synthetically to control the behavior of the enediyne in vivo to make 
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it a more selective molecule.
1 
They were originally isolated from bacteria, various marine and 
terrestrial plant sources as early as the 1960’s, and in 1972, Bergman reported that (Z)-enediynes 
prepared synthetically could undergo thermal cyclization in vitro.
2
 However, it wasn’t until the 
1980s that their anticancer activity was discovered. It was found that their functionality allows 
the enediynes to cyclize, producing a biradical intermediate which imparts biological activity.
2 
These anti-tumour agents interested researchers from a number of disciplines and brought more 
attention to the Bergman cyclization.
3 
Since then, as many as eleven families of natural 
enediynes have been reported.
4
 These families are Calicheamicin (1, R group depends on 
member of family)
5
, Esperamicins (2 and 3)
6
, Dynemicins (4 and 5)
7
, Neocarzinostatin 
chromophores (6 and 7-post activated)
8
, Lidamicins C-1027 (8 and 9)
9
, Kedaricidin (10)
10
, 
N1999-A2 (11)
11
, Maduropeptin (12)
12
, Namenamicin (13)
13
, Shishijimicins (14-16)
14
, and most 
recently, Uncialamycin (17)
15 
(Figure 1). Presently, there has yet to be discovered an anti-tumour 
agent that is more potent than the class of enediyne anticancer agents. 
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Figure 1: Enediyne Anticancer Agents 
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1.2.1 Mode of Action 
 Due to the potent activity, molecular framework and their specific mode of action, these  
compounds can generate cell death in the desired regions. This ability to trigger cell death is due 
to the cytotoxicity of the highly unsaturated hex-3-ene-1,5-diyne unit that can undergo the 
Bergman  cyclization reaction, which in turn generates a benzene-1,4-diradical.
2
 This biradical 
species can then proceed to abstract hydrogen atoms from the sugar-phosphate backbone of 
double stranded DNA.
2
 The biradical species formed from the cyclization of the (Z)-hex-3-ene-
1,5-diyne reacts further to produce DNA strand cleavage, resulting in cell death. The final 
product of the cyclization reaction performed is an aromatic ring.
4
 The mechanism of the 
Bergman cyclization reaction will be discussed further in Section 1.3.  
 There can be many different conditions and structural components arranged which result 
in better control and efficiency of this mode of action. Different chemical properties such as 
electronic, geometric, steric factors, planarity, oxidation states and transition states can affect the 
favourability of the cyclization reaction.
4
 When designing enediynes, all of these characteristics 
must be taken into consideration. In order for the abstraction of hydrogen atoms to take place, the 
chelating unit must be able to insert into the targeted DNA sequence. Therefore, the features of 
the molecule must be designed carefully so that the cyclization biradical intermediate is formed 
in the desired region and can access the DNA. Another important factor in this process is the 
triggering device, which establishes the time and location of the cyclization. If complications 
with the trigger are observed, the desired outcome will not be obtained due to the fact that the 
opposite ends of the enediyne are kept far enough apart so contact, and therefore, cyclization, is 
impossible. Improvements on the triggering mechanism have been reported and will be discussed 
in Section 1.4. 
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1.3 Cycloaromatization 
 As previously discussed, the anti-tumour activity demonstrated from the enediynes 
reviewed would not be observed if the cyclization reaction did not take place.  For this reason, an 
understanding of the mechanism is crucial for the production of these anticancer agents. 
Although there are many cycloaromatization pathways presented in chemistry, the Bergman 
Cyclization reaction will be thoroughly discussed as most of the enediynes function through this 
mechanism.  
 
1.3.1 The Bergman Cyclization Reaction 
 As mentioned earlier, the Bergman cyclization reaction was first reported in 1972 for  
Z-enediynes. After being triggered with heat, the formation of a biradical intermediate was 
proposed. This intermediate species would then abstract protons from a hydrogen donor, 
resulting in the final aromatic product (Scheme 1).
4
 Unfortunately, the mechanism for this 
reaction was poorly understood due to lack of evidence to support the biradical intermediate’s 
presence. However, radical trapping experiments have been subsequently run with the use of 
TEMPO to prove that the biradical intermediate does exist.
16
 Further research provided evidence 
of biradical intermediates in enediynes showing that the intermediates could undergo subsequent 
chemistry characteristic of radical reactions. 
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Scheme 1 
 
 
 
 Herein, using Calicheamicin as an example, a proposed mechanism will be discussed for 
better understanding of the cyclization. Calicheamicin contains two distinct structural regions 
that contribute to biological activity. The largest region, which is the sugar residue, serves to 
deliver the molecule to its target and will bind tightly in the minor groove of the DNA.
17
 The 
second region, referred to as the aglycon, acts as the “warhead” and the trisulfide group serves as 
the trigger. Once the molecule is in the vicinity of the DNA, cleavage may take place due to a 
nucleophile attacking the central sulfur atom, which causes the formation of a thiolate. This 
thiolate attacks the unsaturated ketone which converts the trigonal bridgehead to a tetrahedral 
center. This causes an increase in the strain energy of the 10 membered ring, which is relieved by 
the Bergman cyclization reaction. This produces the highly reactive benzenoid diradical, which 
can then go on to abstract protons from the DNA backbone, causing cell death (Scheme 2).
17
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Scheme 2 
 
 
 
1.3.2 Triggering Mechanisms 
In regards to the natural enediynes’ mode of action, a certain triggering mechanism is in 
place to guarantee control of the cyclization process. Until the trigger is in position, the opposite 
ends of the enediyne are kept apart so an interaction cannot proceed. Once the trigger is activated 
or removed, the ends can be brought together so cyclization can take place. Both the critical 
distance (c-d) and strain factor act synergistically to drive the process to form the biradical 
species. To have better control of the reaction, knowing the critical distance between the two 
ends is essential.  Nicolaou and his research team studied simple monocyclic enediynes without 
limited strain and tethered the ends with different hydrocarbon chain lengths to successfully 
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determine this distance.
18
 The use of chains with different lengths allowed the distances between 
the terminal carbon of the two alkynes (cd) to be changed. They then went on to perform 
numerous cyclization reactions to determine the distances required at room temperature to allow 
for cyclization. They discovered that the distances must be in the range of 3.20-3.31Å in order 
for the cyclization to take place at room temperature. If the critical distances are longer than this 
range, the reaction cannot proceed without the use of heat or other methods of increasing the 
reaction energy.  
This information proved to be quite interesting to other scientists and the experimentation  
continued. Another group of researchers, Schreiner and his team, analyzed similar compounds to 
those investigated by Nicolaou
18
 and reported a different outcome (28a-f) (Scheme 3).
19
 They 
found that there is no predictive relationship between the alkyne carbon distance and the 
cyclization activation energy. However, they found that similar monocyclic systems were able to 
cyclize at room temperature within a longer cd range. The only compounds that would cyclize, 
28c(n=3) and 28d(n=4), had critical distances calculated to be 3.40Å and 3.90Å.  
Studying the substituent effects on the terminal alkynyl carbons provides evidence that 
the cd distances are a critical factor in the enediynes reactivity due to the Bergman cyclization 
being an endothermic process. Grissom and her research team discovered that the activation 
energy can be raised from 25.1 kcal/mol to 28.1 kcal/mol by simply adding an alkyl group onto a 
terminal carbon of the alkyne.
20 
It was also reported that the energy can be raised to a further 
34.0 kcal/mol with the addition of a second alkyl group. If the substituents on the ends are any 
larger, thereby increasing the cd distances, steric interactions would be detected. In turn, the ends 
would be pushed farther apart, making interaction impossible. This research demonstrates the 
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importance of the cd distances being within this certain range in order for the reaction to 
proceed.  
Scheme 3 
 
 
 
Although these distances play an important role in the cyclization process, other 
substituents have proven to contribute to the reactivity. An increase in rate has been observed 
when electron withdrawing substituents are located adjacent to the alkynyl carbon (29). 
21 
Other 
researchers found that vinyl substituents can increase the activation energy due to the electron 
withdrawing group’s ability to lower the rate of reaction (30,31,32).22,23  More recently, Albugin 
et al.
24,25
 reported that benzannulated enediynes (33) impact the kinetics of the reaction 
significantly when the ortho effect is observed (Scheme 4) (X= OMe, NH3
+
, NO2, CF3). Through 
the interaction of the in-plane acetylenic orbitals and the ortho-substituents, the cyclization can 
be controlled. Hydrogen bonding, hyperconjugation and electron transfer can be observed to 
stabilize the interaction or steric interactions can be implied to destabilize the enediyne. In 
conclusion, the cycloaromatization reaction has presented researchers with numerous 
opportunities for developing strategies to make enediynes more selective molecules. Herein, a 
review of synthetically designed enediynes that have been structured to enhance Bergman 
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cyclization reactivity, and decrease toxicity while using favorable triggering mechanisms, will be 
presented. 
 
Figure 2: Various Substituted Enediynes 
 
 
Scheme 4 
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1.3.3 Internal and External triggering in vivo 
 One alternate solution used to develop target-specific chemotherapeutic agents, is the use 
of pH and photo-irradiation cyclization as the triggering method. Kar et al report that greater 
selectivity against tumour cells is expected with pH triggering due to the tumour cells having an 
acidic pH, which can be lowered by the use of hyperglycaemic agents.
26
 Several enediynes have 
been synthesized and tested amongst cell lines although no specific advantage seems noticeable 
under alkaline conditions. Under mildly basic conditions, the cyclization reaction has taken place 
for select enediynes and has displayed therapeutically useful IC50 values against cancer cells. 
However, lack of selectivity is displayed and therefore high toxicity results which is 
unfavourable.  
An internal triggering approach has also been discovered by Jones and his team.
29 
They 
designed prodrugs that demonstrate selectivity towards certain characteristics found in tumour 
cells such as bulges in nucleic acid targets. They reported that the molecules undergo a 
conformational change when interactions occur with these bulges. This brings the ends of the 
enediyne to the desired critical distance so that cyclization may occur.  
Another approach described in the literature is a light-mediated procedure known as 
photodynamic therapy (PDT).
27 
With the use of an anti-tumour drug and light at a certain 
wavelength from sources such as a laser, this method has become useful for terminating tumour 
cells selectively. Although it displays promising results, PDT is not sufficient for large tumours 
as the light cannot penetrate through the tissue. Therefore, longer wavelengths must be used.  
Another external method has also been approached by Grissom et al, where they 
experimented with thermal cyclization.
30
 Here, the conformational change is observed when 
sufficient energy is applied. However, in order for cyclization to occur in acyclic compounds, 
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high temperatures are needed in vitro. Yet cyclic systems can cyclize at lower temperatures to 
relieve ring strain due to their shorter bond critical distances.
28
 
 Most recently, a group of researchers designed 13-membered cyclic enediynes which 
displayed marginal to good inhibition for select cell lines (Figure 3). 
28 
An external method of 
activation was used by applying light in the desired region. In order for this method to be 
successful, the enediynes designed had to remain stable until activation at the specific 
wavelength. In turn, they had to ensure the wavelength of light did not damage the cells 
independently. This method proved advantageous as a photo-irradiation trigger can display 
selective treatment to particular regions. However, as mentioned earlier, not all tumours can be 
reached by the photo-irradiation light.  
 
Figure 3: Sharma’s Synthetically Designed13-Membered Cyclic Enediynes 
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1.3.4 Photochemical Triggering 
 Although the triggering mechanisms discussed have shown promising results, the idea of 
using photochemical triggering has become the most interesting approach yet. In 1994, 
Evenzahav and Turro reported that compound 38 underwent a photochemical Bergman 
cyclization by irradiation in different solvents to produce 39 (Scheme 5).
31
 After further research, 
the same group reported that 38 also produced four different products upon photochemical 
activity (Scheme 6).
32
 They also reported that compound 43 underwent cyclization to produce 
the compound 44 (Scheme 7).   
Scheme 5 
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Scheme 6 
 
 
A mechanism for this photochemical Bergman cyclization has been proposed by this 
group (Scheme 8). Based on the theory of the quantum yield of fluorescence which depends on 
the rigidity of the molecule, they proposed that the cyclization begins in the singlet excited state 
and that the photoreduction occurs in the triplet excited state.
33 
When the enediynes are less rigid, 
chances of deactivation, such as intersystem crossing, are higher which could be problematic. 
However, the aromatic benzene rings shown in 43 make the compound more rigid and less 
susceptible to intersystem crossing. This explains why 43 only forms one cyclization process, 
since photoreduction occurs from the triplet state. The opposite is displayed for compound 38, as 
it is less rigid, granting further production of intersystem crossing (Scheme 9).  
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Scheme 7 
 
 
Scheme 8 
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Scheme 9 
 
 
More recently, Polukhtine and his team synthesized enediynes that improved yields of 
cyclized products by adjusting the electronic properties of substituents.
34
 They also used 
different modes of excitation energy transfer hoping to alleviate toxicity and allow spatial and 
temporal control of the reactivity. They found that when tested in tumour cells, 46 did not 
produce DNA damage whatsoever (Scheme 10). Alternately, 47 is generated in situ and survives 
until encountering DNA. It then goes on to induce single to double stranded cleavage of dsDNA 
with moderate efficiency.  
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Scheme 10 
 
 
1.4 Carbon-Carbon Cross Coupling Reactions 
 In order to design anti-tumour agents, a synthetic approach must be considered. One of 
the most common methods used to produce enediynes is through carbon-carbon cross coupling 
reactions. The reactions proceed with the use of a metal catalyst and vinyl or aryl halides 
coupling with acetylenes.  Since the 1960s, synthetic chemists have been experimenting with 
different cross coupling methodology and are still to this day working to improve reaction 
conditions. 
 
1.4.1 Stephens-Castro Coupling 
 One of the earliest cross coupling reactions reported which experimented with alkynes 
and aryl halides was by Stephens and Castro.
35
 In 1963, they discovered that compound 51 can 
be formed by reacting an aryl iodide with a cuprous acetylide in refluxing pyridine (Scheme 11). 
Heterocyclic compounds were formed when the aryl iodide contained an ortho nucleophilic 
substituent due to a subsequent cyclization reaction. The order of reactivity observed for the aryl 
halides was found to be I>Br>Cl with F showing no reactivity at all. It must also be noted that 
the reactions progressed with more success if the electron withdrawing groups or poorly 
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donating groups are attached in the para position. The order of reactivity for these substituents is 
as follows: p-NO2 > p-H > p-CH3O. However, they did recognize difficulty with cuprous 
acetylide production and it also displayed much instability. Nonetheless, this research paved the 
way for different types of coupling reactions to be explored. 
 
Scheme 11 
 
 
1.4.2 Sonogashira Coupling  
 The Stephens-Castro reaction struck the interest of chemists Sonogashira and Hagihara, 
who then reported success in the coupling reaction by adding a catalytic amount of copper (I) 
iodide.
36
 This copper catalyst displayed a better rate of formation for alkynylation at room 
temperature. The original Sonogashira reaction conditions involve PdCl2 (the main catalyst), 
PPh3(ligand), CuI(cocatalyst) and triethylamine (other amine solvents can be used) (Scheme 12). 
The PdCl2 and PPh3 ligate together which changes the electronic and steric properties of the 
catalyst. The role of the amine is to neutralize the reaction by removing any acidic materials 
while also acting as a solvent. The participation of CuI co-catalyst is not completely understood, 
however the acceleration of the reaction is observed when it is included in the synthesis.
37, 38 
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Scheme 12 
 
 
 The exact mechanism for the Sonogashira reaction is actually unknown, but a proposed  
mechanism has been reported (Scheme 13).
39 
It is believed to take place in two independent 
catalytic cycles, the first being the palladium cycle. In the first cycle, a fast oxidative addition is 
observed when the R1-X (R1=aryl, heteroaromatic, vinyl; X=I, Br, Cl, OTf) complex enters the 
palladium cycle. The R1-X complex interacts with the active catalyst which is generated from 
the original palladium complex, a 14-electron Pd
0
L2 species results from a reduction of the 
different palladium (II) species.  As the reaction proceeds, the intermediate interacts with the 
copper co-catalyst in the second cycle. The rate determining transmetalation reaction taking 
place in the copper cycle generates an alkyne complex, which undergoes a trans/cis 
isomerization and reductive elimination to produce the final coupled alkyne. The complete 
regeneration of the catalyst is also obtained. The second cycle, the copper cycle, is even more 
poorly understood. In theory, it is claimed that the base abstracts a proton from the alkyne 
forming a copper acetylide in the presence of a copper (I) salt.  
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Scheme 13 
 
 
 
 Since this discovery, there have been some improvements in the Sonogashira coupling 
with regards to the catalyst. The most common catalysts used to date are Pd(PPh3)4 and 
PdCl2(PPh3)2. Although the mechanism is not completely understood, the reaction has been 
successful using both Pd
0
 and Pd
+2
 catalysts.  However, this reaction proceeds under much 
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milder and easier conditions than the Stephens-Castro reaction; it still requires purification as 
side reactions often take place, generating homocoupled products.  
  
1.4.3 Cross-coupling of Unactivated arenes 
 Although Sonogashira coupling has proved to be a successful pathway to form carbon-
carbon bonds, other synthetic approaches using unactivated arenes have demonstrated more ideal 
conditions. The costly preactivated starting materials, added reactions, undesirable side/by 
products, generated waste and purification can be decreased by inducing cross-coupling of 
unactivated arenes. This direct activation of a C-H bond permits the direct arylation forming a C-
C bond from two unactivated arenes. In 2007, David R. Stuart and Keith Fagnou
43
 reported their 
methodology requiring a specifically chosen catalyst capable of reacting with one arene in the 
first step of the catalytic cycle to avoid production of homo-coupling and eliminate consumption 
of the starting material and production of unwanted by-products. The catalyst would then invert 
its selectivity in the second step of the cycle and react with the second arene. This inversion in 
selectivity and reactivity is the most crucial and difficult challenge in cross-coupling reactions. 
 Stuart and Fagnou describe their achievement with direct arylation using benzene and an 
electron rich indole or pyrrole. Palladium (II) trifluroacetate was the chosen catalyst 
accompanied by the oxidant copper (II) acetate. Not only did the reaction provide high yields of 
coupled product, high regioselectivity was observed for the C-3 arylated product when this 
specific oxidant was used (Scheme 14). They also found that when they implemented the oxidant 
silver acetate instead, direct C-2 arylation of the indole was observed.
44
 The mechanism for C-H 
cross-coupling reactions is not fully understood or yet determined due to many reasons. 3-
Nitropyridine and cesium pivalate, additives in the reaction, are said to stabilize palladium (0) 
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before it is oxidized back to palladium (II), but this is still not fully conclusive. The sensitivity of 
C3/C2 selectivity for arylation has been compared by using varying amounts of catalysts and has 
been proven that 2 mol% of palladium catalyst offers high desirable isomeric ratios that depend 
on the oxidant used in the reaction.  When the amount of catalyst is increased, the selectivity is 
decreased even though the reaction is proven to be very successful.  Also, even though there is 
much reactivity observed for indoles with electron-donating groups, no clear trends have been 
observed with respect to benzene or other heteroaromatic compounds.
43 
 
Scheme 14 
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In conclusion, cross-coupling synthesis has progressed immensely over the past few 
decades and has led to numerous discoveries. In regards to enedyiene chemistry, new antitumor 
agents have been generated, along with different methods for the synthesis of these compounds. 
Even though this experimentation has been investigated for the past 30 years, only a few 
enediynes have been FDA approved and are used to treat a few diseases such as myeloid 
leukemia.
40,41 
 In this thesis, Sonogashira coupling and photochemical activation of the Bergman 
cyclization reaction will be used to synthesize aromatic enediynes and subsequently test their 
biological activity. In Chapter Two, the synthetic methodology of these compounds will be 
discussed along with the reasoning behind each procedure. Chapter Three will consist of an 
interpretation of the biological activity displayed by these enediynes, once they have been tested 
between certain cell lines. Chapter Four will describe a separate study of direct arylation of 
heteroaromatic arenes with benzene. 
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CHAPTER TWO: A STUDY OF ENEDIYNE SYNTHESIS 
 
2.1 Introduction 
 In Chapter One, a review of enediyne chemistry was presented along with the synthetic 
methodology used for their syntheses, and a discussion of different approaches to triggering the 
Bergman cyclization reaction. It has been noted that past methodology which relied on the non-
specific enzymatic triggering mechanism of the cyclization reaction is lacking in a number of 
ways and there has been greater success implementing photochemical triggering via UV light. 
Herein, methodology towards the synthesis of enediynes designed to undergo the Bergman 
cyclization reaction photochemically in vivo will be discussed, along with the rationale behind 
the production of each compound.  
 In this chapter, the initial stages of various methodologies to synthesize enediynes are 
presented. As mentioned previously, in order to undergo the Bergman cyclization reaction each 
compound must consist of two alkyne substituents. Therefore, starting the Sonogashira coupling 
reaction with an arene that consists of two heteroatoms will make this possible. The enediynes 
can then be designed specifically to include favourable substituents that would be promising 
candidates for cyclization. The first step of this methodology incorporates a Sonogashira 
coupling reaction between an alkyne and 2-bromoiodobenzene (Scheme 15).  
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Scheme 15 
 
 
Due to the presence of the iodide heteroatom, the reactivity at C-1 is much higher than 
the reactivity at C-2. As a result of the reactivity differences between iodides and bromides, the 
reaction can be stopped after one coupling has taken place, compound 59 can then be isolated 
and undergo another Sonogashira reaction with a second alkyne (Scheme 16). Due to each 
coupling reaction taking place individually, different alkynes containing different substituents 
can be coupled to test the reactivity of the final enediyne.  
 
Scheme 16 
 
 
 After a second Sonogashira coupling reaction has been completed, the 1,5-diyne-3-ene 
desired structure is produced (60). It can then be tested under the photochemical Bergman 
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cyclization reaction conditions in hopes that the biradical intermediate will be generated, and 
therefore result in the desired cell death (Scheme 17) in vivo. Due to the fact that the substituents 
can be chosen in the initial stages of the Sonogashira coupling reactions, the reactivity of the 
enediynes can be manipulated so that the best outcome can be observed, that is cell death under 
photochemical conditions only. As previously mentioned, the Bergman Cyclization can take 
place under various conditions due to its ability to cyclize under thermal and photochemical 
reaction pathways. Therefore, the R and R’ substituents on the second benzene ring of the final 
product are determined by the substitution displayed on the enediyne, provided by the two 
alkynes.  
 
Scheme 17 
 
 
 Herein, a synthetic strategy will be discussed that illustrates the production of enediynes 
that will be able to undergo Sonogashira coupling and photochemical Bergman cyclization in 
vivo. These enediynes have been specifically designed to be thermally stable and biocompatible 
in stable cells, along with having the ability to form the biradical intermediate only after 
application of UV light. The functionalities of the substituents have been selected to display 
different characteristics such as electron withdrawing and donating abilities, so that different 
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reactivities can be observed.  The viability of select cell lines, in the presence of these 
synthetically designed enediynes, after being triggered selectively, will be discussed in Chapter 
Three. 
 
2.2 Designing Enediynes 
 The research goal for this project is to design enediynes that can be synthesized via 
Sonogashira coupling and can cyclize photochemically through the Bergman cyclization 
reaction. It is believed that the molecules synthesized in this thesis will have specific features 
that give them the desired reactivity to increase cell death (Figure 4). They have been designed to 
adsorb light at wavelengths that should cause less damage directly on the cells and only increase 
cell death in selective locations due to their strong chromophoric characteristics. They have 
molecular features such as pyrrole rings that allow importation into the cells, which can be found 
in hemoglobin, bioavailable molecules that have the capability to easily go into cells. 
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Figure 4: Enediynes Designed to Increase Cell Death 
 
 It has been decided that the first alkyne to undergo the Sonogashira coupling reaction and 
perhaps the easiest, are the R substituents. Due to the fact that most of these enediynes contain a 
benzene substituent, they can be easily modified.  By changing between electron-donating and 
electron-withdrawing substituents it is hoped that a trend will emerge that leads to enhanced 
reactivity and decreased cytotoxicity to healthy cells.  Some substituents chosen, such as R3 and 
R4, have the ability to hydrogen bond with the DNA backbone and could help aid in cellular 
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interactions. Other substituents chosen have lone pairs of electrons that should display a longer 
wavelength of absorption, thereby lowering the wavelength of light energy required. 
 As for the second Sonogashira coupling reaction, the three alkynes chosen were (2-
propynol) pyrrole-2-carboxylate (R’1), 2-propynol pyridine-3-carboxylate (R’2), and 3-
ethynylpyridine (R’3). Each alkyne contains nitrogen in the different sized ring systems, since 
there has been great success reported in the literature with nitrogen containing compounds. Two 
of the compounds contain an ester linkage that should aid in DNA cleavage and breakup the 
direct chromophore of the two rings. In turn, they can absorb light at a longer wavelength and 
require less energy for cyclization, which would be less harmful to the cells. The pyridine 
containing alkyne lacks this ester linkage, and therefore should display a long chromophore. 
Herein, the compounds that were synthesized via this methodology will be presented and 
discussed.   There will also be a discussion of molecules that we could not successfully prepare. 
 To rationalize the hypothesis that these specifically designed enediynes will undergo the 
Bergman cyclization reaction, the theoretical cd distances were calculated for all compounds. 
These results can be observed in Table 1. It can be noted that the distances fall outside the 
critical ranges determined by Nicolaou and Schreiner by approximately 0.1Å. However, as 
mentioned previously, if the separation of the ends is outside their ranges, the reaction must be 
driven by the addition of energy, thermal or photochemical. Therefore, it seems plausible based 
on the results in Table 1 that the enediynes should cyclize when irradiated by UV light. 
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Table 1: Theoretical Calculations for the cd Distance
a 
R R’1 R’2 R’3 
R1 4.060 4.069 4.117 
R2 4.071 4.077 4.046 
R3 4.074 4.071 4.049 
R4 4.082 4.060 4.062 
R5 4.071 4.061 4.049 
R6 4.077 4.076 4.046 
R7 4.070 4.069 4.056 
R8 4.095 4.049 4.054 
R9 4.025 3.936 4.094 
a
: Calculations were done using MM2 minimization with Chem Draw 
2.3 Synthetic Studies on Enediynes  
 
2.3.1 Preparations for Sonogashira Coupling 
 Before the Sonogashira coupling reactions could begin for the monocoupled and 
dicoupled products, certain starting materials needed to be synthesized. Fortunately, 3-
ethynylpyridine was commercially available from Sigma-Aldrich, but 64 and 66 needed to be 
synthesized. These syntheses were done by performing a simple esterification reaction on 
pyrrole-2-carboxylate acid and nicotinic acid with propargyl alcohol (Scheme 18 and Scheme 
19).  
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Scheme 18 
 
Scheme 19 
 
 
 Substituents R8 and R9 were synthesized by adding a protecting group on the nitrogen 
through a pivaloylation reaction of 4-ethynylaniline and 3-ethynylaniline (Scheme 20 and 
Scheme 21). This reaction was performed using methodology presented by Stuart and Fagnou.
44
 
The exact reaction conditions for these reactions can be found in Chapter Five in the 
experimental section.  
 
 
 
 
33 
 
 
Scheme 20 
 
 
Scheme 21 
 
 
2.3.2 Formation of Monocoupled Products 
 In order to begin the Sonogashira methodology, the most effective catalyst must be 
chosen in order to maximize the alkyne coupling results. Based on successful previous work in 
the Gottardo lab for the preparation of enediynes, different Pd-catalysts, 
tetrakis(triphenylphosphine) palladium (0) [Pd(PPh3)4] (71) and palladium (II) acetate 
[Pd(OAc)2] (72) were selected.
66
  Both catalysts were chosen to determine if one would produce 
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higher yields than the other, as one is Pd
0
 and the other Pd
II
. It was anticipated that the reactions 
would be successful using the Pd(OAc)2 catalyst, so that the unwanted triphenylphospine and 
triphenylphosphine oxide side products which are generated when using the Pd 0 catalyst could 
be eliminated, as they are tedious to separate from the desired product. The amine chosen was 
triethylamine since it was used most frequently in the literature. CuI was used as a co-catalyst 
and the reactions were run for 5 hours at 110
0
C based on classic Sonogashira reaction conditions.  
 The first stage of the Sonogashira coupling reaction is to yield a product with one alkyne 
in the C-2 position (Scheme 22).  Compound 79, (2-bromophenylethynyl)trimethylsilane was 
purchased from Sigma-Aldrich, so the first step of the Sonogashira coupling was unnecessary.  
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Scheme 22 
 
From previous work in the Gottardo lab, it was known that compound 80 can be 
successfully synthesized. It was then hypothesized that the rest of the monocoupled products 
could easily be formed through the same procedure. As previously mentioned, all of compounds 
80-87 were formed with both catalysts for yield comparisons and the results are tabulated in 
Table 1. Although it seems that the Pd(PPh3)4 catalyst produced higher yields for most 
compounds, Pd(OAc)2 was used to make more starting materials. This was decided due to the 
fact that the only major by-products formed by these reactions were triphenylphosphine and 
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triphenylphosphine oxide, which could be eliminated by simply using the palladium (II) acetate 
catalyst. However, both reaction pathways led to the final product after purification through 
column chromatography, which removed any unwanted compounds. Once the products were 
purified, gas chromatography-mass spectrometry (GCMS) analyses were run to make sure the 
separation was successful and the desired product was obtained.  
 
Table 2: Percent Yields of Monocoupled Products 
Catalyst 80 81 82 83 84 85 86 87 
Pd(PPh3)4 
(63) 
56% 43% 66% 75% 57% 56% 12% 14.5% 
Pd(OAc)2 
(64) 
84% 20% 30% 32% 54% 11% ND ND 
 
 After all nine monocoupled products were synthesized; it was possible to begin the 
second stage of the Sonogashira coupling reaction. The formation of the enediyne proved to be 
the most challenging and time consuming step in all of the enediyne synthetic process.  
 
2.3.3 Formation of Enediynes 
 After the monocoupling products were produced, the methodology for coupling the 
second alkyne needed to be determined (Scheme 16). Considering the monocoupled product was 
produced quite easily with reasonable yields in most instances, using the same methodology 
seemed acceptable. The reactions were originally run at 110
o
C for five hours using the same 
amounts of materials as described in Chapter Five. However, these reaction conditions did not 
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prove to be successful. Herein, the modifications tried on each reaction to produce the desired 
enediyne will be discussed along with the results obtained from each synthetic approach.  
 
2.3.3.1 Formation of Enediynes with Ester Linkages 
 In previous years in the Gottardo lab, compounds 79 and 80 were reacted with 64 for 
approximately 24 hours and produced the desired enediynes using the same conditions as 
previously mentioned. However, when the reactions were tried for the work presented in this 
thesis, these results could not be produced. All compounds, 79-87, were tried with 64 using 
different amounts of both catalysts and CuI, different temperatures ranging from 0
o
C-140
o
C and 
different lengths of reactions including running up to 72 hours. Each reaction seemed to only 
produce the unwanted by-products from the Pd(PPh3)4 when used, and unreacted monocoupled 
starting material. In most cases, (2-propynol) pyrrole-2-carboxylate could not be found as 
unreacted starting material in the final product. After numerous failed attempts, a different 
method to achieve the second coupling was attempted. It was thought that the N-H group on the 
pyrrole was interfering in the coupling process via hydrogen bonding and that the reaction might 
be more successful with a protecting group. A pivaloylation reaction was run on 64, (Scheme 23) 
using the same conditions that had allowed us to successfully produce 68 and 70.  
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Scheme 23 
 
 Reactions were run again with all nine monocoupled products with 88 using the different 
reaction conditions described previously, and the enediynes still would not form. Another option 
to be rid of the interfering hydrogen on 64 was to try coupling the monocoupled products with 2-
propynol pyridine-3-carboxylate, 66. Compounds 79-87 were reacted with 66 using the multiple 
conditions tried with 64 and yet again, no dicoupled products were observed and another 
approach needed to be taken into consideration. It was surmised that the aromatic groups on 64 
and 66 were too bulky to be attached second, so coupling them first would eliminate this issue. 
Compounds 64, 66 and 88 were all reacted with 2-bromoiodobenzene using the same reaction 
conditions for the monocoupled products, except they were run for 48 hours (89) and 72 hours 
(90, 91) (Scheme 24 and 25). 
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Scheme 24 
 
Scheme 25 
 
 Compound 91 seemed to form in just trace amount and no further attempts to characterize 
this compound were made, even after several experiments. Perhaps this compound could be 
produced if the reaction was run longer, but this theory could not be tested due to time 
constraints.  The preparations of compounds 89 and 90 were successful and they were reacted 
with alkynes 79-87 in an attempt to obtain the desired enediyne product. Again, all reactions 
were run at different temperatures with different catalyst amounts and monitored over a 72 hour 
period to check the progression of the reactions. The reactions did not proceed efficiently and no 
product was formed. It was difficult to determine why the reactions were not successful but a 
few ideas have been considered. Due to these reactions being run at different times of the year, 
ambient humidity in the laboratory could be affecting the reaction conditions. Perhaps there was 
too much steric strain occurring in the ring system due to these alkyne groups being too bulky 
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and these circumstances prevented activation. Also, there were some difficulties with the 
production of the Pd(PPh3)4 catalyst. At first, it seemed to oxidize and change colour over a few 
days which resulted in questions around its reactivity in the reactions. Although, once the 
procedure was perfected and the right colour of the catalyst was obtained, the desired products 
were still not formed.  
 
2.3.3.2 Formation of Enediynes with 3-ethynylpyrridine 
 Fortunately, a more productive outcome was observed when reacting the monocoupled 
products with 3-ethynylpyridine. The reactions produced the desired enediynes rather simply 
after a few modifications of the original conditions were applied. The reactions were first tried 
for 5 hours at 110
o
C with 2% of the palladium catalysts. After GCMS analysis, it was found that 
minimal product was formed using Pd(PPh3)4, and the starting materials did not seem to react 
with the Pd(OAc)2 catalyst. Due to these results, the reactions were run for 24 and 48 hours with 
Pd(PPh3)4 at 130
o
C until it was observed that 72 hours optimized production of product. 
However, the yields determined are still quite low. Our first successful reaction utilizing this 
methodology was done with 3-ethynylpyridine and (2-bromophenylethynyl)trimethylsilane, 
resulting in 92 (Scheme 26). Compound 92 can be separated from the reaction mixture via 
column chromatography very easily but in poor yields (11%). This was found acceptable as very 
little was needed for the cell testing. After changing the amount of catalyst to 4% and the 
temperature back down to 110
o
C, the other 8 enediynes were synthesized. Compound 93 was 
produced using 1-bromo-2-(2-phenylethynyl) benzene as the first alkyne, and it proved to be 
very easily isolated with a 13% yield. It was predicted that these two enediynes should show 
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biological activity as similar molecules containing a phenyl substituent in place of the pyridine 
substituted had shown activity in experiments run previously in the Gottardo lab.  
 
Scheme 26 
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 Compounds 96, 97 and 98 were also successfully synthesized and purified albeit in low 
yields of 12.5%, 12% and 25%, respectively. However, at first the same outcome did not seem to 
be observed for compounds 94 and 95. These reactions were run with the exact same conditions, 
but the GCMS showed only trace product being formed with no reason to purify further. After 
many different tries changing the amount of catalyst, temperature and time of reaction, the 
enediynes still did not seem to form. It was hypothesized that as for 64, the hydrogens on the 
NH2 group were interfering with the reaction and were preventing the formation of the enediyne. 
In order to prevent this from happening, 3-ethynylpyridine was tried as the first alkyne to be 
coupled using the same conditions for the monocoupling reactions (Scheme 27).  
 
Scheme 27 
 
 
 Compound 102 was synthesized easily when run for a 72 hour period, purified and 
yielded 13% of product. It was then reacted with 3-ethynylaniline (75) and 4-ethynylaniline (74) 
under various reaction conditions, but once again, minimal product seemed to form (Scheme 28).  
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Scheme 28 
 
 
As with 64, a pivaloylation reaction was run on both 3-ethynylaniline (Scheme 20) and 4-
ethynylaniline (Scheme 21) to produce compounds 68 and 70 with 14.5% and 12% yields. These 
compounds were reacted with 102 via Scheme 28 and via Scheme 26 and yet again, the end 
result did not seem promising. This seemed very peculiar. All of the crude products formed from 
the different reaction schemes (Scheme 26 and 28) of each compound (94, 95, 99, 100) were 
characterized via NMR spectroscopy and IR spectroscopy. The data collected from the NMR and 
IR spectra are consistent with the formation of the desired products. What if the product was 
successfully synthesized through these reactions but the product was too sticky and could not be 
detected via GCMS? A direct injection ION TRAP was run on each compound and proved that 
the enediyne was in fact produced and in reasonable amounts. These compounds were then 
purified by column chromatography and produced the following yields: 12% (94), 14% (95), 4% 
(99), 9% (100). Compounds 99 and 100 were not deprotected so that they could also be tested for 
biological activity against the cells. Although only 9 of the 27 proposed enediynes were formed 
in this thesis, the question of whether or not these enediynes would undergo the Bergman 
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cyclization reaction and produce cell death in the desired regions was still investigated. These 
procedures and results are presented in Chapter Three.  
 
2.4 Future Work 
 It has been demonstrated that the Sonogashira coupling reaction can be applied 
effectively to the synthesis of both homo- and heterodisubstitued enediynes. Additional work 
must be performed in order to extend the range of enediynes which can be produced. Other 
substituents should be synthesized to study reactivity in vivo. Due to successful previous work in 
the Gottardo lab, other reaction conditions could be tried to produce enediynes with 64, 66, and 
88. Other commercially available alkynes could also be studied, with similar characteristics and 
functionality.  
 The thermal cyclization of these compounds could also be investigated. Due to their 
calculated c-d values, they should be able to undergo the Bergman cyclization in vitro, which 
would have been explored if more time was provided.  
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CHAPTER THREE: A STUDY OF THE BIOLOGICAL ACTIVITY OF 
PHOTOACTIVATED ENEDIYNES 
 
3.1 Introduction 
 In Chapter One, a review of enediyne chemistry was presented along with synthetic 
methodology used for the synthesis of these compounds. As mentioned previously, enediynes are 
of interest due to their specific functionality that allows them to impart biological activity. This 
functionality is known to cyclize via a Bergman biradical intermediate which is then capable of 
cleaving DNA.
2 
In vivo, it has been shown that this cyclization is triggered enzymatically, which 
results in reduced selectivity and increases cytotoxicity.
3 
Numerous attempts have been reported 
in the literature to control the cyclization of enediynes through the use of photo-irradiation 
triggering of the enediynes.
26
 However, after 30 years of investigating photoactivated enediynes, 
to date there are still only few drugs which have been approved by the FDA.  
 Since the cytotoxicity of enediynes is not limited to tumour cells or diseased cells, 
synthetic analogues have been proposed. The design of enediyne analogues requires that the pro-
drug nature of the molecule be maintained to ensure that the “triggering” can occur selectively in 
the desired cells. These triggers can be internal or in this case, external to the cell. An external 
method of activation to cyclization, thermal cyclization, relies upon sufficient energy being 
applied to promote the conformational change. Due to cyclic systems having the advantage of 
shorter bond critical distances (Figure 1), cyclization can occur more readily at lower 
temperatures to relieve ring strain.
28 
External triggers such as light can also be applied.
34 
However, it is extremely important to ensure that the light sensitive molecules are stable in vivo 
until activation by a specific wavelength and that the wavelength of activation is not in itself 
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damaging to the cells. Triggering via photo-irradiation is advantageous as it can be selectively 
applied to specific treatment areas, although this could be limiting as not all tumours can be 
reached by photo-irradiation.  
 The approach presented in this thesis relies on the synthesis of enediynes, which are 
thermally stable under biological conditions, that cyclize to generate the reactive biradical after 
the application of light (Scheme 29). Due to enediynes having three different sections, optimal 
functionality, a delivering and triggering system, these compounds can be modified synthetically 
to control the behavior of the drug in vivo to make it a more selective molecule. Chapter Two 
presents the enediynes that have been synthesized and designed to have sufficient 
biocompatibility to enter the cells but also be stable within the cell environment until activation. 
Herein, the anti-cancer activity of these compounds tested on two different cell lines will be 
presented and discussed.  
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Scheme 29 
 
 
3.2 Cell Culture and Testing 
 The nine enediyne compounds synthesized in this thesis were tested on two types of cells, 
cancerous and non-cancerous cell lines. They were first tested against human alveolar type II-
like epithelial A549 cancer cells. These cells are squamous in nature and are responsible for the 
diffusion of certain substances such as water and electrolytes, across the alveoli of the human 
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lungs. They also have the ability to synthesize lecithin and contain a high percentage of 
desaturated fatty acids, which are utilized by the cytidine-diphospho-choline pathway and are 
important for the maintenance of membrane phospholipids in cells.
67
 This cell line was chosen 
due to its cancerous characteristic and its ability to absorb light at the desired wavelength. The 
other cell line chosen was the non-cancer H9c2 cardiomyocytes. This myoblast cell line was 
derived from embryonic rat heart
68
 and was chosen so that a comparison of non-cancerous and 
cancerous cell lines could be established.  Both cells were readily available and proved to be 
good candidates with enediyne testing in the Gottardo lab previously. 
 The experiments were performed using serum-free media. Before the testing could take 
place, each cell line needed to be thawed, grown and split so that the required amount of cells 
could be obtained. Once each line was fully grown and prepared, they were seeded into sterile 
flat-bottom 96-well plates at 10 000 cells/well and grown to 80% confluence overnight. In the 
meantime, the enediynes were added to the serum-free media so that it could dissolve and be 
taken up by the cells. However, this was not the case. The enediynes would not dissolve directly 
into the media. Previously in the Gottardo lab, the enediynes were dissolved in a 1% 
DMSO/ethanol solution and then added to the media, but when this was tried they did not stay 
dissolved in the media. Adding up to 1mL of DMSO was tried and still the drug candidate came 
out of solution. This was very problematic as if the cells did not dissolve in the media, they could 
not be tested. After much research, it was decided that Tween 80 may be the best solution to this 
solubility issue.
69 
Each enediyne was mixed with 200 µL of Tween 80 and after sitting overnight 
and stirring with a sterile micro spatula and vortex, the compounds fully dissolved in the media.  
After 24 hours of incubation of the cells, the media was removed and replaced with 
control, control and Tween 80, or the enediyne containing media. Each enediyne was tested at 
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two different concentrations (7 and 15 µM final concentration) with three wells per concentration 
in two plates. After 3 hours and 50 minutes of pre-incubation of the A549 or H9c2 cells with 
enediynes, one plate containing the drug were activated with a 10 minute or 6.5 minute exposure 
to 302 nm UV light, and were then incubated for a further 16 hours. The length of irradiation was 
chosen to ensure that the cells did not overheat. It was found by previous monitoring of 
temperature that longer time frames resulted in temperature increase that could be harmful to the 
cells. Control cells with and without Tween 80 were also exposed or left in the incubator with the 
other non-exposed plate. Each enediyne was characterized via UV spectrometry (Chapter Five), 
and it was found that the absorbance’s ranged from 230-328nm. Due to this observation, treating 
the cells at 302 nm seemed appropriate. 
After the 16 hour incubation period was complete, the culture media (150µL) was 
replaced with fresh media containing 10% yellow MTT (Thiazolyl Blue Tetrazolium Bromide) 
reagent and then incubated for an additional four hours. The culture media was then aspirated 
and 50 µL of dimethylsulfoxide was added per well to solubilize the formazan crystals, and the 
absorbance of each well was measured.  
 
3.3 Anti-cancer Activity Results 
 The absorbances were measured spectrophotometrically at a wavelength of 490 nm (650 
nm background correction wavelength), 8 watts, 115 V, ~60 Hz and 0.7 Amps using a 
PowerWave XS Microplate Spectrophotometer (BioTek, Winooski, VT, USA). Cell death of 
challenged cells was assessed relative to control cells. The results for each compound 92-100 
(Scheme 26) are reported in Table 3 and 4. The original report of absorbance readings from the 
BioTek microplate reader can be found in Appendix I and Appendix II.  
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Table 3: Cell Death of human alveolar type II-like epithelial A549 cells in the Presence of 
Enediyne 
Compound Concentration (µm) % Cell Death 
No UV Exposure UV Exposure 
92 7 83.10 81.31 
15 70.77 77.24 
93 7 81.78 74.80 
15 61.44 78.46 
94 7 84.33 82.53 
15 78.80 79.27 
95 7 83.9 81.71 
15 77.54 70.74 
96 7 85.20 86.18 
15 90.25 86.58 
97 7 86.44 78.86 
15 72.88 77.65 
98 7 85.20 92.28 
15 89.00 89.80 
99 7 92.80 89.03 
15 91.53 89.03 
100 7 90.68 87.40 
15 87.70 79.67 
Control 0  ~0 
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Table 4: Cell Death of H9c2 cells in the Presence of Enediyne 
Compound Concentration (µm) % Cell Death 
No UV Exposure UV Exposure 
92 7 90.77 76.89 
15 68.12 72.86 
93 7 82.23 75.88 
15 79.62 70.61 
94 7 79.45 75.13 
15 58.54 51.51 
95 7 87.28 75.38 
15 82.06 68.60 
96 7 81.19 76.38 
15 82.41 75.13 
97 7 84.67 72.86 
15 84.67 76.64 
98 7 85.37 73.37 
15 83.28 73.37 
99 7 92.16 84.44 
15 ND ND 
100 7 87.29 81.41 
15 86.59 79.65 
Control 0  30.66 
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3.4 Cytotoxic Properties of Activated Enediynes- Cell Death 
As previously mentioned, the compounds tested were designed specifically to have the 
ability to undergo the Bergman cyclization reaction with the addition of light, and increase cell 
death due to their desired reactivity characteristics. The enediynes have electron-donating and 
electron-withdrawing substituents that should enhance reactivity and decrease cytotoxicity and 
others have the ability to hydrogen bond with the DNA backbone to aid in cellular interactions. 
Compounds with substituents with lone pairs of electrons should also technically display a 
longer wavelength of absorption and lower the wavelength of light energy required. Each of 
these compounds were tested at two different concentrations to see if the effect of the drug would 
increase or increase cell death at higher or lower concentrations. Each enediyne was tested in 
three wells per concentration with UV or without so that an average could be taken for better 
results. Due to previous trial and error experimentation in the Gottardo lab, the cells were 
irradiated at 10min (A549) and 6.5min (H9c2). They found that when the H9c2 cells were 
irradiated for longer than 6.5 minutes, cell death was increased significantly. However, if t ime 
was permitted, other times would have been tried and altered to optimize results for these 
specific drugs. 
 Control groups consisted of the cells challenged alone or with UV light alone. They were 
also tested this way with Tween 80, but were not included in Table 3 & 4 as the results seemed 
to suggest complete cell death, which should not be the case. Exposure of A549 cells to UV light 
resulted in slightly less than 0% cell death. This also seemed strange as the value should not be 
less than 0%, so experimental error has been observed here as well. When compounds 92-100 
were tested with and without ultraviolet light, cell death was greatly increased compared to the 
control. However, the standard values (no UV exposure) are very similar which raises the 
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question of how effective the drug was. Also, unfavorable patterns have been observed for most 
compounds. For compounds 92-94, 97, the cell death decreased after the application of light for 
7µM, which should not be. This was also found for both concentrations for compounds 95, 99-
100. In some cases, cell death was found to be greater for 7µM as opposed to 15µM, which is 
very unusual as the high concentration should be displaying a higher increase in cell death. 
However, compound 92 enhanced the cytotoxicity to 77.24% (15µM),  93 to 78.46% (15µM),  
94 to 79.27% (15µM),  96 to 86.18% (7µM), 97 to 77.65% (15µM), 98 to 92.28% (7µM) and 
89.80% (15µM). This suggests that these compounds do have the ability to increase cell death 
under photochemical conditions. However, a DNA extraction was not completed and it is 
unknown of whether or not the drug killed the cells or if other factors affected the results.  
 The exposure protocol of the H9c2 cardiomyocytes to the di-alkynes and/or UV light was 
the same as the one used for the experiment with the A549 cells, except for the length of time 
irradiated. The exposure of H9c2 cells to UV light resulted in 30.66% cell death. However, a lot 
of the same patterns observed for A549 cells were observed here as Tween 80 was also used. All 
compounds except for 92(15µM) displayed a smaller amount of cell death when UV light was 
applied when compared to the standard UV exposure values which should again not be the case. 
Only compound 92(15µM) displayed an enhancement of cytotoxicity to 72.86%. Compound 99 
could not be run at 15µM as there was not enough of the compound available to be tested.  
The standard no UV exposure values observed should be approximately 0% since the 
drug should be able to survive in the cells until the application of light. This determines that 
either the enediyne is killing the cells or the Tween 80 is. Based on previous results obtained in 
the Gottardo lab, in which enediynes only increased cell death by less than 85% it can be 
extrapolated that the enediyne should not be harming the cells in this way; it appears that there 
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may have been problems with the Tween 80. The Tween could be potentially blocking the light, 
making the Bergman cyclization reaction impossible to proceed. It could be that the Tween is 
toxic to the cells or perhaps it is destroying the drug before addition to the cells. A bad batch of 
Tween 80 could have also been used, which may have been harmful to the cells. In no way 
should the cells be growing after the application of light, which was displayed in most cases and 
displayed great experimental error.  
 
3.5 Future Work 
 In theory, the drugs designed in this thesis should display marginal to good inhibition 
when tested between the cell lines used. However, this was not necessarily the result obtained 
from this research. Additional work must be performed in order to optimize these results. Most 
importantly, improving the solubility of the compounds to ensure testing without Tween would 
be desirable. Attempts should be made to see if the compounds could be dissolved in less than 
200µL of Tween 80 to see if the amount of Tween 80 accelerated cell death. Other methods of 
dissolving the compounds should also be tried, such as other solvents or surfactants. Changes in 
the enediyne structure synthetically could also be taken into consideration to make them more 
soluble and stable for the cells. A further decrease of energy of light needed by the extending 
chromophore would be ideal. Also, the amount of time needed for irradiation could be optimized 
by increasing or decreasing the time through trial and error. Perhaps testing other potential cell 
lines for activity would be better for this type of drugs and other choices in media could improve 
solubility issues.  
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CHAPTER FOUR: A STUDY OF DIRECT ARYLATION OF HETEROAROMATIC 
ARENES WITH BENZENE 
 
4.1 Introduction 
There are numerous reports in the literature that describe methods for the synthesis of 
biaryl compounds using favourable cross-coupling reaction conditions. The scientific and 
commercial value of biaryl molecules is demonstrated through their ability to be building blocks 
in liquid crystals, electron transport devices, medicinal compounds and in light emitting diodes. 
These types of compounds are also found in natural products such as alkaloids and are also 
present in commercial dyes. Applications of these compounds towards organic semi-conductors 
and conductors rely on the physical properties of polyaromatic compounds. 
48
 As a result, the 
formation of biaryl compounds has been closely studied over the past 30 years due to the many 
applications these molecules can be part of, ranging from pharmaceutical to materials chemistry. 
Many different methods for biaryl compound synthesis have been established using 
combinations of preactivated, preactivated and unactivated, and just unactivated starting 
materials. In these reactions, the aromatic compounds usually require different arene coupling 
patterns which are activated towards reaction with the help of a palladium catalyst and a copper 
oxidant. The most widely used syntheses of cross-coupling reactions are the Suzuki and the Stille 
reaction both of which couple aryl organometallics and aryl halides.
43 
 
4.1.2 Direct Arylation of Preactivated Arenes 
The Stille reaction involves the coupling of organostannanes with organic electrophiles 
(Scheme 30).
49
 The work of coupling organostannanes was originally discovered in 1976-1977 
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but became a standard method in 1978 with the work of Stille and his research team. This 
reaction seemed quite effective due to its tolerance towards most functional groups resulting in 
the transformations of highly functionalized molecules. Numerous ring systems bearing sensitive 
functional groups have been successfully constructed with the application of the Stille reaction. 
Although the Stille reaction has established itself as one of the most general and most selective 
palladium-catalyzed cross-coupling reactions, the synthesis has many disadvantages which result 
in this reaction not being optimal. The transmetalation step is a complex reaction and can operate 
with different Pd (II) species in solution. Depending upon the catalyst, reagents and the solvent, 
the species can change uncontrollably. The toxicity and low polarity of the tin compounds also 
make them unfavourable starting materials. The solvent and additives can also influence the 
nucleophilicity of the tin reagent. Recent studies carried out on these reactions used electrophiles 
that were unreactive with conventional ligands. These reactions used complexes with sterically 
demanding ligands as catalysts.
49
 A different view of transmetalation to palladium has emerged 
using organotin compounds and other nucleophilic organometallic compounds. These 
observations have suggested that by using other organometallic reagents with less electropositive 
metals, similar dual pathways may be found in these reactions under the appropriate conditions. 
The Suzuki coupling is an example of a cross-coupling reaction that has successfully used less 
electropositive metals.
50
  
 
Scheme 30 
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The 2010 Nobel Prize winner A. Suzuki worked with palladium-catalyzed cross-coupling 
reactions between different types of organoboron compounds and various organic electrophiles 
which included triflates and halides in the presence of a base (Scheme 31). There are many 
advantages to this type of cross-coupling which include mild reaction conditions, high product 
yields and high regio- and stereoselectivity, good water stability, readily available reactants, 
tolerance of a broad range of functional groups and the usage of a small amount of catalyst.
50
 
Also, the reaction is non-toxic, environmentally friendly and can be completed in a one-pot 
synthesis. 
 
In 1981, the first method to cross-couple aryl boranes with haloarenes was reported 
which proceeded even under heterogeneous conditions. Numerous modifications have been 
made to the reaction conditions since 1981 such as using CsF or Bu4NF as bases. Originally, 
phosphine based palladium catalysts were used due to their stability under prolonged heating 
conditions until it was discovered that using palladium catalysts without a phosphine ligand such 
as Pd(OAc)2, also achieved high coupling reaction rates.
50
 The Pd(0) catalyst that is used in these 
basic conditions is generated in situ from either the Pd(OAc)2 or PdCl2.
51 
Although the Suzuki 
reaction is environmentally friendly, constant advances in Suzuki coupling have been made 
throughout the years to obtain even greener reaction conditions and improve the yields. 
 
Scheme 31 
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In 2008, Evangelos Aktoudianakis and his research team at the University of Toronto 
designed a Suzuki reaction with “greenness” to it. This method of cross-coupling uses water as 
the sole solvent in the reaction and an inexpensive palladium on carbon active catalyst. These 
reaction conditions also do not follow the purification protocol as seen in previous Suzuki 
reactions, other than the recrystallization of the solid product. This research team worked with 
phenylboronic acid and 4-iodophenol to produce 4-phenylphenol. These reaction conditions are 
quite favourable due to the use of water because it is a non-flammable solvent that has no 
toxicity issues and is the most cost efficient solvent on an industrial scale.
51 
The Suzuki reaction has been one of the most popular research investigations in academic 
institutions over the past few years. However, there have been many synthetic problems and 
disadvantages with the need for preactivation of starting materials. Due to using preactivated 
arenes, several synthetic steps are required which can generate waste from reagents and can 
become quite costly. Also, the solvents and the purification protocol used in these reactions can 
produce undesired by-products such as homo-coupling.
48
 Therefore; direct C-H arylation of 
unactivated arenes with aryl halides is an attractive approach for biaryl bond formation.  
 
4.1.3 Direct Arylation of Preactivated and Unactivated Arenes 
The most dominant class of C-H bond arylation reactions involves the use of a directing 
group to direct a transition metal into a C-H bond or to promote transition metal oxidative 
addition of a C-X bond (X=halogen). There are also many examples of single-activated cross-
coupling reactions, in which the proposed mechanisms of the reaction rely on the catalyst to 
insert into the activated aryl group first, usually an aryl halide. Once the Ar-M-X species has 
been formed, the unactivated insertion will occur. Numerous reactions have been reported 
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illustrating the success of this type of methodology working with indoles
53,54,55
, thiophenes and 
furans
56
 with aryl halides. Researchers have reported cross-coupling reactions with a directing 
group such as the intermolecular reactions of o-bromophenols
57
 or the use of a removable 2-
pyridylsulfinyl group.
58 
It has been reported that use of the N-directing group of 
benzo[h]quinoline allowed better understanding of the selectivity of the reaction and the 
reductive elimination that produces the C-C bond formation.
59
 A different group of researchers 
also reported successful directing ability of o-phenylcarbamates which selectively produce 
mono- and diarylated products.
60 
In 2011, Wenkun Hong and his research team worked to develop a new method to 
improve the efficiency and generality of this reaction. They worked with preactivated and 
unactivated arenes to produce a Pd-catalyzed direct arylation without the use of directing groups. 
This reaction is environmentally friendly and produces high-yields. The substrates used were 
benzene and 4-methyl iodobenzene with the catalytic assistance of Pd(OAc)2 and benzene as the 
solvent. Salts were also added to the reaction to be used as oxidizing agents, such as AgNO3, 
AgOAc, AgO2CCF3, and Cu(OAc)2 . They reported that the use of additives was less effective 
and produced no yield. To eliminate homo-coupling of biphenyl, the reaction conditions were 
modified to 10 mol % Pd(OAc)s and 1.0 equivalent AgNO3 at 110
o
C (Scheme 32).
52
 In the 
presence of multiple potentially reactive groups at higher temperatures, this methodology shows 
great functional group tolerance and high selectivity. 
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Scheme 32 
 
 
 
Although these synthetic approaches are successful, they unfortunately still use one 
preactivated starting material which can be avoided via other synthetic approaches. The costly 
preactivated starting materials, added reactions, undesirable side and or by products, and 
generated waste from reagents, solvents and purification will be decreased by inducing cross-
coupling of unactivated arenes.  
 
4.1.4 Direct Arylation of Unactivated Arenes 
In order to successfully form a C-C bond in the absence of a directing group, the ability 
to control the reactivity of each species is crucial. The reactivity of the two unactivated starting 
materials and the mechanism of this reaction must be understood in order to result in the desired 
products. Selectivity of heteroarenes with different electron densities that produce different C-H 
bond strengths,
 
and reacting simple arenes with different substituents
 
have been reported.
60,61 
In 
2007, Fagnou et al. reported success in coupling unactivated indole and pyrrole to benzene with 
the use of a palladium catalyst [Pd(TFA)2] and silver/copper oxidants.
43,44
 3-Nitropyridine, and 
cesium pivalate were also used as additives in the reactions. They discovered that when copper 
(II) acetate and the additives were included in the reaction, arylation was directed into the C-3 
position producing no homo-coupling and relatively high yields. This demonstrates complete 
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inversion in catalyst selectively occurring at the crucial arene metallation step of the catalytic 
cycle under mild conditions. Remarkably, it was also found that when implementing the oxidant 
silver (I) acetate with the additives, coupling to the C-2 position was observed with higher 
regioselectivity. Unfortunately, undesirable benzene homo-coupling was observed but was only 
considered as a minimal loss. The reactions were run with different amounts of palladium 
catalyst and were most successful with using only 2 mol%. Different amounts of catalyst were 
tested and it has been reported that when the amount of catalyst is increased, the selectivity is 
decreased even though the reaction is proven to be very successful. Even though there is much 
reactivity observed for indoles and pyrroles with electron-donating groups, no clear trends have 
been observed with respect to benzene. Due to many successes reported in the literature using 
unactivated arenes, further investigation will be discussed on furan coupling to benzene in this 
thesis, along with the reactivity and selectivity of these compounds.  
 
4.2 Synthetic Studies on Unsubstituted and Substituted Furans  
 The reaction conditions for the furan reactions with benzene were designed to match 
Fagnou’s previously reported synthesis with few modifications. Pivalic acid was chosen as an 
additive due to Fagnou’s reported results in 2006, where they discovered that PivOH (Pivalic 
acid) works as a cocatalyst providing a key component anion in the C-H bond cleaving. This 
anion lowers the dissociation energy of the C-H thereby operating as a catalytic proton 
transporter from benzene to a base.
62 
Benzoquinone was used as an additive instead of 3-
nitropyridine based on results from Sanford who reported success with using a substoichiometric 
quantity of 1,4-benzoquinone in order to promote the oxidative coupling reaction.
63 
Due to 
benzoquinone’s unique structure, it has the ability to influence regioselectivity with certain 
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arenes by acting as a ligand during the selectivity-determining step.
64
 This conclusion has 
depended on the production of a C-H activated palladium benzoquinone intermediate which then 
initiates a second C-H activation of a substituted benzene. Herein, similar energy demands have 
been observed for this reaction sequence.  
Due to cross-coupling reaction mechanisms not being fully understood, Palladium II and 
Palladium 0 catalysts were chosen in this thesis to see if there is any correlation observed to the 
coupling product and the catalyst. Two of the three palladium catalysts chosen for these reactions 
are Pd(TFA)2 and Pd(OAc)2 which provide both monomeric and dimeric Pd
II
 species. The third 
catalyst chosen, Pd(PPh3)4, is a Pd
0
 bearing a phosphine instead of an oxygen ligand. The 
reactions were run using the same oxidants, silver and copper (II) acetate, as Fagnou reported 
successful C2/C3 selectivity with in 2007. Four unactivated aromatics were investigated: Furan, 
2-Furaldehyde, 2-methylfuran and 2,3-benzofuran. These compounds were chosen based on their 
different electron withdrawing and electron donating characteristics. Herein, we report the 
reactivity and selectivity observed for these compounds when different substituents, additives, 
catalysts and oxidants are implemented in various combinations. 
 
4.3 Results 
 The reaction conditions chosen for each arene and the observed outcome are presented in 
Table 5. Although the reported yields for each reaction are quite low, there are some interesting 
patterns detected with regards to reactivity and selectivity.  
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Scheme 33 
 
 
 
Table 5: Carbon-carbon Bond forming results for O-Containing Heteroatoms 
 
Entry R Pd-
catalyst 
Oxidant Additive Yield % 
(113:114)
a
 
Conditions
b
 
1 H Pd(OAc)2 AgOAc None <1% 
(14:86) 
A 
2 H Pd(OAc)2 Cu(OAc)2 None <1% 
(44:56) 
A 
3 H Pd(OAc)2 AgOAc Benzoquinone NR B 
4 H Pd(OAc)2 Cu(OAc)2 Benzoquinone NR B 
5 H Pd(TFA)2 AgOAc None <1% 
(1<100) 
A 
6 H Pd(TFA)2 Cu(OAc)2 None NR A 
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7 H Pd(TFA)2 AgOAc Benzoquinone <1% 
(30:70) 
B 
8 H Pd(TFA)2 Cu(OAc)2 Benzoquinone NR B 
9 H Pd(PPh3)4 AgOAc None 1.4% 
(53:47) 
A 
10 H Pd(PPh3)4 Cu(OAc)2 None <1% 
(80:20) 
A 
11 H Pd(PPh3)4 AgOAc Benzoquinone <1% 
(41:59) 
B 
12 H Pd(PPh3)4 Cu(OAc)2 Benzoquinone <1% 
(67:33) 
B 
13 CH3 Pd(OAc)2 AgOAc None 5.1% 
(100>1) 
A 
14 CH3 Pd(OAc)2 Cu(OAc)2 None 1% 
(100>1) 
A 
15 CH3 Pd(OAc)2 AgOAc Benzoquinone 1% 
(100>1) 
B 
16 CH3 Pd(OAc)2 Cu(OAc)2 Benzoquinone NR B 
17 CH3 Pd(TFA)2 AgOAc None 1% A 
18 CH3 Pd(TFA)2 Cu(OAc)2 None 1% A 
19 CH3 Pd(TFA)2 AgOAc Benzoquinone 1.4% B 
20 CH3 Pd(TFA)2 Cu(OAc)2 Benzoquinone NR B 
21 CH3 Pd(PPh3)4 AgOAc None 3.6% A 
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22 CH3 Pd(PPh3)4 Cu(OAc)2 None 1% A 
23 CH3 Pd(PPh3)4 AgOAc Benzoquinone <1% B 
24 CH3 Pd(PPh3)4 Cu(OAc)2 Benzoquinone <1% B 
25 CHO Pd(OAc)2 AgOAc None 5.8% 
(100>1) 
A 
26 CHO Pd(OAc)2 Cu(OAc)2 None <1% 
(73:27) 
A 
27 CHO Pd(OAc)2 AgOAc Benzoquinone 30.8% 
(100>1) 
B 
28 CHO Pd(OAc)2 Cu(OAc)2 Benzoquinone 7.5% 
(100>1) 
B 
29 CHO Pd(TFA)2 AgOAc None 21.8% 
(79:21) 
A 
30 CHO Pd(TFA)2 Cu(OAc)2 None 1.4% 
(84:16) 
A 
31 CHO Pd(TFA)2 AgOAc Benzoquinone 22.9% 
(98:2) 
B 
32 CHO Pd(TFA)2 Cu(OAc)2 Benzoquinone 6.1% 
(100>1) 
B 
33 CHO Pd(PPh3)4 AgOAc None 9.4% 
(93:7) 
A 
34 CHO Pd(PPh3)4 Cu(OAc)2 None <1% 
(100>1) 
A 
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35 CHO Pd(PPh3)4 AgOAc Benzoquinone 33.3% 
(97:3) 
B 
36 CHO Pd(PPh3)4 Cu(OAc)2 Benzoquinone 9.5% 
(100>1) 
B 
37 CHO Pd(OAc)2 AgOAc Pyridine <1% C 
38 CHO Pd(OAc)2 Cu(OAc)2 Pyridine 5.9% C 
39 CHO Pd(OAc)2 AgOAc None 5.8% A + PivOH (6 
eq) 
40 CHO Pd(OAc)2 AgOAc Benzoquinone 19% 
(1:15) 
D 
41 CHO Pd(OAc)2 Cu(OAc)2 Benzoquinone 17% E 
42 CHO Pd(PPh3)4 AgOAc Benzoquinone 12% F 
43 CHO Pd(OAc)2 AgOAc Benzoquinone 17% F 
44 -(CH=CH)2- Pd(OAc)2 AgOAc None <1% A 
45 -(CH=CH)2- Pd(OAc)2 Cu(OAc)2 None <1% A 
46 -(CH=CH)2- Pd(OAc)2 AgOAc Benzoquinone <1% B 
47 -(CH=CH)2- Pd(OAc)2 Cu(OAc)2 Benzoquinone 1.4% B 
48 -(CH=CH)2- Pd(TFA)2 AgOAc None 2.5% A 
49 -(CH=CH)2- Pd(TFA)2 Cu(OAc)2 None <1% A 
50 -(CH=CH)2- Pd(TFA)2 AgOAc Benzoquinone 1.3% B 
51 -(CH=CH)2- Pd(TFA)2 Cu(OAc)2 Benzoquinone <1% B 
52 -(CH=CH)2- Pd(PPh3)4 AgOAc None 2.0% A 
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53 -(CH=CH)2- Pd(PPh3)4 Cu(OAc)2 None <1% A 
54 -(CH=CH)2- Pd(PPh3)4 AgOAc Benzoquinone 1.0% B 
55 -(CH=CH)2- Pd(PPh3)4 Cu(OAc)2 Benzoquinone <1% B 
56 -(CH=CH)2- Pd(TFA)2 AgOAc Pyridine <1% C 
57 -(CH=CH)2- Pd(TFA)2 Cu(OAc)2 Pyridine 1.1% C 
a
 Where no ratio of 113:114 is given, only compound 113 was detected by GC; 
b
 Conditions : 
A.  Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol) and Pd-catalyst (0.05 mmol) 
were combined in a vial containing dry benzene (2.7 mL), sealed and heated to 110 
o
C for five 
hours;  B. Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), benzoquinone (2.0 
mmol, 216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-catalyst (0.05 mmol) were 
combined in a vial containing dry benzene (2.7 mL), sealed and heated to 110 
o
C for five 
hours; C. . Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), 4-methyl-3-
nitropyridine (2.0 mmol, 216 mg), cesium pivalate (mmol, mg),  pivaloyl acid (6.0 mmol, 613 
mg)  and Pd-catalyst (0.05 mmol) were combined in a vial containing dry benzene (2.7 mL), 
sealed and heated to 110 
o
C for five hours; D. Heteroaromatic compound (1.0 mmol), oxidant 
(6.0 mmol), benzoquinone (2.0 mmol, 216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-
catalyst (0.05 mmol) were combined in a vial containing dry benzene (2.7 mL), sealed and 
heated to 110 
o
C for five hours; E. Heteroaromatic compound (1.0 mmol), oxidant (1.5 
mmol), benzoquinone (2.0 mmol, 216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-catalyst 
(0.05 mmol) were combined in a vial containing dry benzene (2.7 mL), sealed and heated to 
110 
o
C for five hours; F. Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), 
benzoquinone (2.0 mmol, 216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-catalyst (0.05 
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mmol) were combined in a quartz tube containing dry benzene (2.7 mL), sealed and irradiated 
via UV light for five hours. 
 
4.4 Discussion 
 Although similar synthetic conditions were followed, much lower yields were observed 
for furan and benzene coupling compared to Fagnou’s research. For the unsubstituted furan 
reactions (Entries 1-12), less than a 5% yield was observed even when the additives were 
included. It can also be seen that in the presence of benzoquinone, the reactivity is decreased, 
opposite to Sanford’s observations. For all of the reactions with a regioselectivity of greater than 
2:1, 3-phenylfuran was produced with the AgOAc oxidant while the 2-phenylfuran was produced 
with the Cu(OAc)2 oxidant, which is the opposite of Fagnou’s reported selectivity patterns. 
However, there is no observation of dimerization production of bifuran or biphenyl and there is 
no evidence of diphenyl substitution occurring on the furan.  
 As for the substituted furan compounds, low yields were also observed with or without 
the use of additives. The overall reactivity seems to decrease when the electron-donating 2-
methylfuran (Entries 13-24) is reacted with the copper oxidant and benzoquinone promoter. 
There seems to be no production of the 4-phenylsubstitution and the product of 3-
phenylsubstitution is formed with both silver and copper oxidant with less than 5% yield. With 
the 2,3-benzofuran (Entries 44-57), the Cu
2+
 adversely affects the reactivity and little is gained 
by the presence of a promoter. Again, no production of the 4-phenylsubstitution is observed, and 
the 3-phenylsubstitution is produced with no more than 3% yield unlike previously reported 
literature.
65
 The 2-furaldehyde reactions (Entries 25-43) were the only ones that showed reaction 
progress. Up to a 33% yield was observed for the reaction containing the copper oxidant, 
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benzoquinone and the Pd(PPh3)4 catalyst. It is also observed that again, the copper oxidant 
seemed to decrease the reactivity. 2-Furaldehyde was the only substituted furan that showed 
evidence of 2- regioisomers. As displayed in Table 5, it can be observed that the C-3 substitution 
is favoured in the presence of the copper oxidant but it is also favoured in the presence of 
AgOAc. Reactions were run with 2,3-benzofuran and 2-furaldehyde using nitropyridine instead 
of benzoqunione to see if Fagnou’s exact conditions would produce more success (Entries 
37,38,56,57). Unfortunately, the same observations were made for these compounds as when 
they were run with benzoquinone.  
Two separate reactions were run for 2-furaldehyde changing the amount of the oxidant 
used to see if the same results would be observed. The reactions were run with Pd(OAc)2, 
PivOH, benzoquinone and either half or double the amount of the oxidant. Both of these 
reactions were run to determine if the amount of the cation, copper versus silver, (6.0 mmol vs. 
1.5 mmol) is the aspect of the oxidant change that governs changes in the overall reactivity or the 
C2/C3 selectivity. The reaction run with 6.0 mmol of AgOAc (Entry 40) seemed to result in 
products at the C-3 position and minimal amounts of C-2 products with a 19% yield and the 
reaction run with 1.5 mmol of Cu(OAc)2 (Entry 41) produced only the C-3 coupled product with 
a 17% yield. Also, the two reactions which produced the best yield were run again, using the 
same reaction conditions except they were reacted via UV light. 2-Furaldehyde was chosen to 
run with benzoquinone, silver acetate and with Pd(PPh3)4 (Entry 42) and Pd(OAc)2 (Entry 43). 
Entry 42 produced the C-3 product along with trace amounts of the C-2 coupled product (12% 
yield), whereas Entry 43 only formed the C-3 product with a 17% yield. 
Overall good selectivity was seen for the 2-furaldehyde reactions, but not for the other 
substituted and unsubstituted furans. In most cases only one product was formed with a greater 
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than 3:1 ratio. In light of the poor yields observed in the absence of a promoter or with the use of 
benzoquinone promoter, other reactivity patterns were observed opposite to those reported in the 
literature. In order to determine if the reactivity demonstrated by indole and pyrrole was 
intrinsically tied to the N-containing promoter; a few reactions were run with 4-methyl-3-
nitropyridine instead of benzoquinone. As mentioned earlier, the yields did not improve nor did 
any ratios of product change. On the other hand, it was noticed that the copper oxidant was more 
successful in the coupling reactions than the silver oxidant. Recently, successful arylation has 
been reported without the use of promoters although PivOH additive is included. These reaction 
conditions were also applied as well as no PivOH, as shown in Table 5. However, no further 
improvement on the outcome of these reactions was observed. When the oxidant amount was 
increased to 6.0 mmol (Entry 40), yields were decreased by at least half compared to the original 
reaction conditions (Entry 27) and both compounds were produced. On the other hand, when the 
oxidant was decreased to 1.5 mmol (Entry 41), yields improved compared to the original 
reaction (Entry 28) and still only one product was formed. Both of these observations lead to 
suspicion of whether or not the amount of oxidant affects the yields and C2/C3 selectivity. It is 
hard to conclude if this is the case as only two reactions were run, thus future experimentation 
could lead to explanation of the relationship between reactivity/selectivity and oxidant. It is also 
interesting to note that Entries 42 and 43 were successfully synthesized via UV light. Although 
yields were much lower than the original protocol (Entries 35, 27), the same product was 
obtained in each case. Similarly, this creates vast synthetic opportunity for direct arylation on 
these compounds.   
Even though the yields were quite low, some product was formed for each starting 
heteroaromatic species. This proves that C-H activation arising from a palladium intermediate 
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did occur and could perhaps be optimized by altering some conditions. The fact that the 
palladium catalyst is only being used at a 5% mole factor and the reactions are run for only five 
hours could potentially prevent a successful turnover. In an attempt to optimize these yields, 
some reactions were run for 24 hours at 110
o
C (Table 5), and some improvements have been 
recognized. The electron- withdrawing furaldehyde arenes yield rose to 35% from 30%, while 
the rest of the compounds did not show much improvement. However, these reactions did 
maintain their high level of selectivity and no increase of homo-coupling products were detected.   
 
4.4 Future Work 
 As mentioned previously, the fact that some product was obtained for each starting 
heteroaromatic implies that C-H activation did occur and therefore demonstrates that these 
reactions could be optimized in the future. The reaction conditions can be altered to optimize 
yields and selectivity. Reactions could be run at higher temperatures for longer periods of time, 
and the amount of palladium catalyst can be adjusted. The amount of oxidant used can also be 
increased or decreased based on the results found in this thesis when using either half or double 
the original amount. Since the most promising results were shown with an electron withdrawing 
reactant, different compounds could be tested using the same conditions that also have this 
characteristic. Lastly, reactions could be run with each heteroaromatic arene under UV light as 
somewhat successful results were found with the two reactions run on 2-furaldehyde. 
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CHAPTER FIVE: EXPERIMENTAL 
 
5.1 Experimental 
 
5.1.1 General Experimental Technique, Instrumentation and Materials 
 Analytical gas chromatography (GC) was performed on a Hewlett Packard 5890 
equipped with a flame ionization detector (FID) using a 30 m by 0.25 mm DB-5HT capillary 
column of (5% phenyl)methylpolysiloxane. The carrier gas was helium or nitrogen with a flow 
rate of 2.0 mL/min and a column head pressure of 21 psi. The temperature program used was the 
following: initial temperature = 50
o
C, initial time = 3 minutes, rate = 8
o
C/minute, final 
temperature = 280
o
C, final time = 2 minutes. Gas chromatography-mass spectrometry (GCMS) 
was performed on a Varian 460GC-300 MS/MS chromatogram equipped with a 30 m by 0.25 m 
Varian FActorFour VF-5 ms Capillary Column. The carrier gas used was helium with a linear 
velocity of 25.5 cm/s at 80
o
C and a column head pressure of 11.5 psi. The temperature program 
used was the following:  
Table 6: Temperature Program for Varian 460GC-300MS/MS 
 Temperature 
(
o
C) 
Rate (
o
C/min) Hold (min) Total (min) 
1 45  2 2 
2 155 8 0 15.75 
3 275 50 11 29.15 
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The gas chromatograph was connected to a Varian 300 MS/MS which measured the mass of 
samples between 40 and 500 mass units with a resolution of 0.7 Da at 1250 Da/sec or 0.6 Da at 
500 Da/sec and an ionizing potential of 70 eV at 200
o
C and detector voltage of 1280V and 
accelerating voltage of constant @ 5kV. Mass spectral data are reported in ion counts and 
recorded in the following fashion: parent ion (relative intensity), m/e of significant fragments 
(relative intensity). The Ion Trap chromatograph used was a Bruker Amazon X Ion Trap with an 
ESI ionization, a -4500V capillary, -500V End Plate Offset and a 10psi, 5 l/min dry gas, 200
o
C 
dry temp Nebulizer, infused @ 240µL/hour.  
 Proton nuclear magnetic resonance (
1
H NMR) spectra were measured on a Varian AS500 
using the 
UNITY
INOVA NMR spectrometer system, VNMR 6.1C software and a switchable PFG 
NMR probe at room temperature (unless otherwise indicated). The solvent used was CDCl3 
unless otherwise stated. Chemical shifts are reported in parts per million (ppm) from an internal 
standard of tetramethylsilane (TMS). 
13
C NMR spectra were also recorded using CDCl3 as the 
solvent unless otherwise stated and TMS as the internal standard on the same spectrometer. The 
NMR data are reported as follows: chemical shift (for 
1
H NMR signals: multiplicity, coupling 
constant in Hertz, integration). 
 Infrared (IR) spectra were measured on a Bruker IFS-66 Fourier transform infrared 
(FTIR) spectrometer with a resolution of 4 cm
-1
. All spectra were determined using CDCl3 unless 
otherwise noted, in the transmission mode using NaCl plates and are reported as wavenumbers. 
Ultraviolet spectra were measured using a Perkin-Elmer Lambda 11 spectrometer, in 
dichloromethane using a quartz cuvet, and are reported as wavelength of maximum absorption 
(in nm) with the corresponding molar absorptivity (ε). 
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 A Varian Vista Pro Radial ICP-AES was used to detect trace amounts of palladium in 
select samples before cell testing was run. The Varian Vista Pro CCD simultaneous ECP-OES 
was used with a CETAC ASX-510 Auto sampler. Samples were dissolved in minimal amount of 
concentrated HCl and then diluted with deionized water. Low amounts of palladium were 
detected and reported in ppm and the samples were further purified before biological activity was 
tested. 
 All experiments were run under a positive pressure of nitrogen in flasks that were either 
flame or oven dried. Air and moisture sensitive reagents were transferred by syringe and 
introduced to the reaction flasks through rubber septa. Excess solvents were removed in vacuo at 
pressures obtained by a water aspirator drawing on a Buchi rotary evaporator. All compounds 
were stored at room temperature under atmospheric conditions or in the refrigerator unless noted 
otherwise. Diisopropylamine and benzene were distilled from phosphorus pentoxide. All other 
solvents were used as received.  
 Analytical thin layer chromatography (TLC) was performed on silica gel of 5-17 µm 
particle size, 60Å pore size, with a thickness of 250 µm, containing a 254 nm fluorescent 
indicator. The solvents used for chromatography are indicated in parentheses in the procedures 
and the relative concentrations are calculated by volume.  Spots were viewed using ultraviolet 
light. Column chromatography was used to purify the reaction mixtures and was accomplished 
using 60-200 mesh grade silica gel and the solvent systems were determined by analytical TLC.  
 Tetrakis(triphenylphosphine)palladium(0)(71)
42 
was synthesized using previously 
described methods.  All other chemicals for which procedures are not listed were purchased from 
Aldrich. 
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4.2 Preparations 
 
4.2.1 Experimental for Chapter Two 
2-Propynol pyrrole-2-carboxylate 64 
 To a flame dried, three-neck round bottom flask (25 mL), pyyrole-2-carboxylic acid (222 
mg, 2.0 mmol) was added with a magnetic stir bar. Thionyl chloride (0.18 mL, 297 mg, 2.5 
mmol) was added dropwise over 30 minutes. The solution was then heated by reflux at 80
o
C 
until it began to darken (approximately 30 minutes). The solution was then cooled in an ice bath 
to 0
o
C. Propargyl alcohol (0.15 mL, 140 mg, 2.5 mmol) was added dropwise slowly; maintaining 
the reaction temperature below 10
o
C. The reaction was then refluxed for 30 minutes at 75
o
C. Ice 
water (10 mL) was added to the mixture and extracted with diethyl ether (10 mL x 3). The 
combined organic extract was washed with saturated NaHCO3 (10 mL x 1) and dried with 
MgSO4. The mixture was then filtered through Celite by gravity and excess solvent removed in 
vacuo. A 30% yield of 2-propynol pyrrole-2-carboxylate was obtained as determined by GC. 
TLC(2:1, Ethyl Acetate:Hexanes): 0.51. 
UV: λmax = 266 (є = 141). 
IR(CDCl3): 3456, 3307, 2924, 2253, 1703, 1553, 1417, 1309, 1161, 908, 731. 
1
H NMR(CDCl3): δ 9.24(s, 1H, NH), 7.21-6.98(m, 2H, Ar-H), 6.28(dd, J= 2.5 Hz,2.5 Hz, 1H, 
Ar-H), 4.87 (d, J= 2.5 Hz, 2H, CH2), 2.49 (t, J= 2.0 Hz, 2.0 Hz, 1H, CH). 
13
C NMR(CDCl3): δ 160.3, 123.6, 116.4, 110.9(2C), 77.9, 75.1, 51.9.  
MS: 149(47), 104(25), 94(100), 66(21), mass calcd for C8H7O2N m/z 149.0570, obsd m/z 149.1. 
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2-Propynol N-trimethylacetylpyrrole-2-carboxylate 88 
 2-Propynol pyyrole-2-carboxylate (2.533g, 0.017mmol) and DMAP (0.2197g) were 
added to a 100 mL round bottom flask and purged with N2.  Dry dichloromethane (30 mL) was 
then added via syringe producing a brown solution. Triethylamine (3.6 mL) was then added and 
the solution was cooled to 0
o
C in an ice bath. Pivaloyl chloride (2.5 mL) was added over a 1 
minute period and the solution was stirred at 0
o
C for approximately 10 minutes. The mixture was 
then warmed to room temperature and allowed to stir overnight. The following day the solvent 
was removed in vacuo and partitioned between 50 mL of saturated NH4Cl and 50 mL of 
diethylether. The organic layers were washed with saturated sodium chloride (40 mL) and the 
aqueous layers were back extracted with diethyl ether. The solvent was removed in vacuo and 
the product purified by column chromatography (15% diethyl ether/ hexanes). A 26% yield of 
was obtained as determined by GC. 
TLC(2:1, Ethyl Acetate:Hexanes):0.51. 
UV: λmax = 265 (є = 28). 
IR(CDCl3): 3457, 3307, 2950, 2253, 1701, 1553, 1450, 1435, 1416, 1310, 1163, 1127, 1108, 
991, 908, 734, 734, 649.  
1
H NMR(CDCl3): δ 7.03(d, J=33 Hz, 2H, Ar-H), 6.25 (s, 1H, Ar-H), 4.83(d, J=17.5 Hz, 2H, 
CH2), 2.50(s, 1H, CH), 1.35(s, 9H, 3 CH3). 
13
C NMR(CDCl3): δ 182.32, 159.64, 125.15, 118.92, 116.33, 110.24, 75.19, 74.96, 52.09, 43.45, 
27.72, 27.59, 26.98. 
MS: 233(9), 176(92), 120(100), 57(33), mass calcd for C13H15O3N m/z 233.1151, obsd m/z 
233.3. 
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2-Propynol pyridine-3-carboxylate 66 
 To a flame dried, three-neck round bottom flask (25 mL), Nicotinic acid (246 mg, 2.0 
mmol) was added with a magnetic stir bar. Thionyl chloride (0.18 mL, 297 mg, 2.5 mmol) was 
added dropwise over 30 minutes. The solution was then heated by reflux at 80
o
C until it began to 
darken (approximately 30 minutes). The solution was then cooled in an ice bath to 0
o
C. 
Propargyl alcohol (0.15 mL, 140 mg, 2.5 mmol) was added dropwise slowly; maintaining the 
reaction temperature below 10
o
C. The reaction was then refluxed for 30 minutes at 75
o
C. Ice 
water (10 mL) was added to the mixture and extracted with diethyl ether (10 mL x 3). The 
combined organic extract was washed with saturated NaHCO3 (10 mL x 1) and dried with 
MgSO4. The mixture was then filtered through Celite by gravity and excess solvent removed in 
vacuo. A 46% yield of 2-propynol pyridine-3 carboxylate was obtained as determined by GC. 
TLC(2:1, Ethyl Acetate:Hexanes): 0.21. 
UV: λmax = 234 (є = 14), 263 (14).  
IR(CDCl3): 3307, 3154, 2952, 2253, 1731, 1592, 1421, 1371, 1277, 1110, 915, 746, 650. 
1
H NMR(CDCl3): δ 9.27 (s, 1H, Ar-H), 8.82 (d, J= 4.0 Hz, 1-H, Ar-H), 8.34 (t, J= 2.0 Hz, 1H, 
Ar-H), 6.42 (m, 1H, Ar-H), 4.97 (d, J=2.5 Hz, 2H, CH2), 2.56 (t, J= 2.5 Hz, 1H, CH). 
13
C NMR(CDCl3): δ 164.5, 153.8, 151.1, 137.3, 137.2, 123.4, 77.2, 75.5, 52.8. 
MS: 161(100), 106(97), 78(83), 51(70), mass calcd for C9H6O2N m/z 161.057, obsd m/z 161.1. 
 
3-ethynyl-N-trimethylacetylaniline 68 
3-Ethynylaniline (1.56 mL, 0.017 mmol) and DMAP (0.2197g) were added to a 100mL 
round bottom flask and purged with N2.  Dry dichloromethane (30 mL) was then added via 
syringe producing a brown solution. Triethylamine (3. 6mL) was then added and the solution 
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was cooled to 0
o
C in an ice bath. Pivaloyl chloride (2.5 mL) was added over a 1 minute period 
and the solution was stirred at 0
o
C for approximately 10 minutes. The mixture was then warmed 
to room temperature and allowed to stir overnight. The following day the solvent was removed in 
vacuo and partitioned between 50 mL of saturated NH4Cl and 50 mL of diethyl ether. The 
organic layers were washed with saturated sodium chloride (40 mL) and the aqueous layers were 
back extracted with diethyl ether. The solvent was removed in vacuo and the product purified by 
column chromatography (15% diethyl ether/ hexanes). A 75% yield of was obtained as 
determined by GC. 
TLC(2:1, Ethyl Acetate:Hexanes): 0.61. 
UV: λmax = 236 (є = 343). 
IR(CDCl3): 3450, 3305, 3064, 2968, 2906, 2872, 2251, 1673, 1603, 1583, 1483, 1420, 1303, 
908, 815, 733, 687, 650.  
1
H NMR(CDCl3): δ 7.65(s, 1H, Ar-H), 7.59(d, J=4.5 Hz, 1H, Ar-H), 7.27(t, J=5 Hz, 1H, Ar-H), 
7.23(d, J=6.5 Hz, 1H, Ar-H), 3.04(s, 1H, NH), 3.06(s, 1H, CH), 1.28(s, 9H, 3 CH3’s). 
13
C NMR(CDCl3): δ 176.64, 138.05, 129.7, 127.0, 123.41, 122.0, 120.54, 83.14, 77.37, 39.65, 
27.58(3C). 
MS: 201(99), 117(97), 57(100), 41(43), 201(95), 117(81), 57(100), exact mass calcd for 
C13H15ON m/z 201.1179, obsd m/z 201.1. 
 
4-Ethynyl-N-trimethylacetylaniline 70 
4-Ethynylaniline (1.99g, 0.017 mmol) and DMAP (0.2197g) were added to a 100 mL 
round bottom flask and purged with N2. Dry dichloromethane (30 mL) was then added via 
syringe producing a brown solution. Triethylamine (3.6 mL) was then added and the solution 
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was cooled to 0
o
C in an ice bath. Pivaloyl chloride (2.5 mL) was added over a 1 minute period 
and the solution was stirred at 0
o
C for approximately 10 minutes. The mixture was then warmed 
to room temperature and allowed to stir overnight. The following day the solvent was removed in 
vacuo and partitioned between 50 mL of saturated NH4Cl and 50 mL of diethyl ether. The 
organic layers were washed with saturated sodium chloride (40 mL) and the aqueous layers were 
back extracted with diethyl ether. The solvent was removed in vacuo and the product purified by 
column chromatography (15% diethyl ether/ hexanes). A 45% yield of was obtained as 
determined by GC. 
TLC(2:1, Ethyl Acetate:Hexanes): 0.58. 
UV: λmax = 269 (є = 344). 
IR(CDCl3): 3450, 3290, 3168, 3098, 2977, 2874, 2252, 2106, 1666, 1587, 1511, 1401, 1311, 
1239, 1177, 908, 836, 732, 651. 
1
H NMR(CDCl3): δ 7.51(d, J=8.5 Hz, 2H, Ar-H), 7.44(d, J=9 Hz, 2H, Ar-H), 3.04(s, 1H, NH), 
1.73(s, 1H, CH), 1.27(s, 9H, 3CH3’s). 
13
C NMR(CDCl3): δ 176.63, 138.48, 132.90(2C), 119.46(2C), 117.53, 83.38, 65.87, 39.73, 
27.73, 27.61, 27.57, 26.50.  
MS: 201(95), 117(81), 57(100), exact mass calcd for C13H15ON m/z 201.1179, obsd m/z 201.1. 
 
Tetrakis(triphenylphosphine)palladium(0) 71 
 PdCl2 (0.7236 g, 4.1 mmol) and PPh3 (4.9090 g, 18.7 mmol) were mixed together in a 
round bottom flask (250 mL) with DMSO (55 mL). The contents were slowly heated using a 
heating mantle with a condenser over Ar. The solution turned bright yellow. The reaction 
continued to be heated for approximately 1 hour and 45 minutes until the precipitate fully 
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dissolved producing an orange transparent solution. The reaction was then removed from the 
heat and allowed to cool with vigorous stirring. When the yellow precipitate began to reform, 
hydrazine hydrate (1.32 mL, 1.36 g, 27.2 mmol) was added slowly via syringe. The precipitate 
went back into solution and the mixture turned dark brown during the addition. The precipitate 
then began to reform once again and resulted in a volumous yellow precipitate after further 
cooling. The contents were quickly filtered using a Buchner funnel and washed with absolute 
ethanol until the washing became colorless. It was then washed with diethyl ether (25 mL) and 
left to dry on vacuum for a few minutes. The catalyst was then stored under Ar/N2 in the freezer. 
A percent yield of 92.4% was obtained. 
 
The following compounds were synthesized using the general procedures described as either 
Method A or Method B.  
 
Method A:  
2-Bromoiodobenzene (0.13 mL, 283 mg, 1.0 mmol), Pd(PPh3)4 (23 mg, 0.02 mmol) and CuI (7.6 
mg, 0.04 mmol) were combined in a heavy walled reaction vessel with dry diisopropylamine (5 
mL). Alkyne (1.2 mmol) was then added and the mixture was degassed for two minutes with N2 
gas. The reaction vessel was tightly capped and heated for 5 hours at 110
o
C. The reaction was 
then filtered over Celite and washed with diethyl ether (10 mL x 3). The mixture was then 
washed with saturated NaHCO3 (10 mL) and the organic layer was dried with MgSO4. The 
solvent was removed in vacuo and the product purified by column chromatography. 
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Method B: 
2-Bromoiodobenzene (0.13 mL, 283 mg, 1.0 mmol), Pd(OAc)2 (4.49 mg, 0.02 mmol) and CuI 
(7.6 mg, 0.04 mmol) were combined in a heavy walled reaction vessel with dry diisopropylamine 
(5 mL). Alkyne (1.2 mmol) was then added and the mixture was degassed for two minutes with 
N2 gas. The reaction vessel was tightly capped and heated for 5 hours at 110
o
C. The reaction was 
then filtered over Celite and washed with diethylether (10 mL x 3). The mixture was then 
washed with saturated NaHCO3 (10 mL) and the organic layer was dried with MgSO4. The 
solvent was removed in vacuo and the product purified by column chromatography. 
 
1-bromo-2-(2-phenylethynyl)benzene 80 
Method A: 56 percent yield was observed using phenylacetylene (0.13 mL, 123 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).  
Method B: 84 percent yield was observed using phenylacetylene (0.13 mL, 123 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).   
TLC(100% Hexanes): 0.37. 
UV: λmax = 227 (є = 45), 287 (47), 305 (38).  
IR(CDCl3): 3154, 2253, 1492, 1466, 907, 732, 650. 
1
H NMR(CDCl3): δ 7.62-7.55 (m, 3H, Ar-H), 7.36 (t, J= 3.5 Hz, 3H, Ar-H), 7.295 (t, J= 7.5 Hz, 
2H, Ar-H), 7.18 (t, J= 7.0 Hz, 1H, Ar-H).  
13
C NMR(CDCl3): δ 133.2, 132.5, 131.7(2C), 129.4, 128.7(2C), 128.7, 128.4, 127.0, 125.6, 
122.9, 104.9, 93.9, 87.9. 
MS: 255(100), 176(85), 151(64), 88(53), exact mass calcd for C14H9Br m/z 255.9893, obsd m/z 
255.9. 
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2-[(4-Aminophenyl)ethynyl]-1-bromobenzene 81 
Method A: 43 percent yield was observed using 4-ethynylaniline (0.10 mL, 117 mg, 1.2 mmol), 
purified by column chromatography (2:1; Ethyl Acetate: hexanes). 
Method B: 20 percent yield was observed using 4-ethynylaniline (0.10 mL, 117 mg, 1.2 mmol), 
purified by column chromatography (2:1; Ethyl Acetate: hexanes). 
TLC(2:1, Ethyl Acetate:Hexanes): 0.29. 
UV:  λmax = 228 (є = 27), 311 (31). 
IR(CDCl3): 3400, 3036, 2925, 2854, 2252, 2215, 1620, 1584, 1515, 908, 731, 650. 
1
H NMR(CDCl3): δ 7.60 (d, J= 8.0 Hz, 1H, Ar-H), 7.52 (d, J= 6.5 Hz, 1H, Ar-H), 7.40 (d, J= 8.5 
Hz, 2H, Ar-H), 7.26 (t, J= 8.0 Hz, 1H, Ar-H), 7.13 (t, J= 6.5 Hz, 1H, Ar-H), 6.64 (d, J= 9.0 Hz, 
2H, Ar-H), 3.86 (s, 2H, NH2).  
13
C NMR(CDCl3): δ 147.0, 133.1, 132.8, 132.3, 128.7, 126.9, 126.0, 125.3, 114.7(2C), 112.2, 
104.9, 94.9, 86.2. 
MS: 271(100), 191(22), 165(37), 95(31), exact mass calcd for C14H10NBr m/z 271.0599, obsd 
m/z 271.0. 
 
2-[(3-Aminophenyl)ethynyl]-1-bromobenzene 82 
Method A: 66 percent yield was observed using 3-ethynylaniline (0.10 mL, 117 mg, 1.2 mmol), 
purified by column chromatography (2:1; Ethyl Acetate: hexanes). 
Method B: 30 percent yield was observed using 3-ethynylaniline (0.10 mL, 117 mg, 1.2 mmol), 
purified by column chromatography (2:1; Ethyl Acetate: hexanes). 
TLC(2:1, Ethyl Acetate:Hexanes): 0.33. 
UV: λmax = 231 (є = 2586), 286 (2265), 297 (2066). 
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IR(CDCl3): 3394, 2252, 1618, 1600, 1493, 1468, 1445, 911, 730. 
1
H NMR(CDCl3): δ 7.61 (d, J=8.0 Hz, 1H, Ar-H), 7.54 (d, J= 7.0 Hz, 1H, Ar-H), 7.28 (t, J= 7.5 
Hz, 1H, Ar-H), 7.18-7.13 (m, 2H, Ar-H), 6.98 (d, J= 7.0 Hz, 1H, (Ar-H), 6.90 (s, 1H, Ar-H), 
6.68 (d, J= 8.0 Hz, 1H, Ar-H), 3.70 (s, 2H, NH2).  
13
C NMR(CDCl3): δ 146.3, 133.2, 132.4, 129.3, 129.3, 127.0, 125.6, 125.5, 123.6, 122.1, 117.8, 
115.7, 94.2. 87.4. 
MS: 271(100), 191(33), 165(65), 95(29), exact mass calcd for C14H10NBr m/z 271.0599, obsd 
m/z 271.0. 
 
1-Bromo-2-[(3-amino-N-trimethylacetylphenyl)ethynyl]benzene 87 
Method B:  14.5 percent yield was observed using 68 (252mg, 1.2 mmol), purified by column 
chromatography (10% Ethyl Acetate/ hexanes).  
TLC(2:1, Ethyl Acetate:Hexanes): 0.59. 
UV: λmax = 234 (є = 27560), 288 (18609). 
IR(CDCl3): 3450, 3321, 2967, 2857, 2252, 1677, 1604, 1529, 1485, 1163, 908, 787, 734, 649. 
1
H NMR(CDCl3): δ 7.83(dd, J=1 Hz, 1H, Ar-H), 7.74(s, 1H, Ar-H), 7.60-7.57(m, 1H, Ar-H), 
7.51(d, J=6 Hz, 1H, Ar-H), 7.44(s, 1H, Ar-H), 7.31-7.25(m, 1H, Ar-H), 7.21-7.14(m, 1H, Ar-H), 
6.98-6.95(m, 1H, Ar-H), 1.29(s, 9H, 3 CH3’s).  
13
C NMR(CDCl3): δ 178.56, 140.34, 138.14, 133.30, 132.44, 129.46, 129.44, 129.07, 128.39, 
127.52, 127.05, 122.75, 120.29, 93.41, 88.17,39.69,  27.61(3C)           
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1-Bromo-2-[(4-amino-N-trimethylacetylphenyl)ethynyl]benzene 86 
Method A:  12 percent yield was observed using 70 (252mg, 1.2 mmol), purified by column 
chromatography (10% Ethyl Acetate/ hexanes).  
TLC(2:1, Ethyl Acetate:Hexanes): 0.61. 
UV: λmax = 240 (є = 198), 305 (268), 328 (275). 
IR(CDCl3): 3445, 3320, 3060, 2968, 2871, 2249, 2218, 1665, 1584, 1514, 1433, 1402, 1310, 
1165, 1026, 908, 841, 733, 649. 
1
H NMR(CDCl3): δ 7.83(d, J=8 Hz, 1H, Ar-H), 7.66-7.45(m, 4H, Ar-H), 7.25(t, J=7.5 Hz, 1H, 
Ar-H), 7.19-7.12 (m, 1H, Ar-H), 6.96 (t, J=7.5 Hz, 1H, Ar-H), 1.28(s, 9H, 3 CH3’s). 
13
C NMR(CDCl3): δ 176.65, 140.24, 138.42, 132.67, 132.37, 132.35, 131.95, 129.61, 129.40, 
129.20, 126.99, 119.59, 118.21, 93.76, 87.62, 44.93, 39.66, 27.53, 26.67. 
 
1-Bromo-2-[2-(4-toluyl)ethynyl]benzene 83 
Method A: 75 percent yield was observed using 4-ethynyltoluene (0.13 mL, 116 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).   
Method B: 32 percent yield was observed using 4-ethynyltoluene (0.13 mL, 116 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).   
TLC(100% Hexanes): 0.45. 
UV: λmax = 239 (є = 178), 288 (228), 307 (223).  
IR(CDCl3): 3054, 3030, 2922, 2864, 2250, 2220, 1731, 1510, 1467, 1433, 907, 817, 732. 
1
H NMR(CDCl3): δ 7.52 (d, J= 7.0 Hz, 1H, Ar-H), 7.55 (d, J= 6.0 Hz, 1H, Ar-H), 7.49 (d, J=7.5 
Hz, 2H, Ar-H), 7.30 (t, J= 6.0 Hz, 2H, Ar-H), 7.18 (d, J= 7.5 Hz, 2H, Ar-H), 1.57 (t, J= 6.5 Hz, 
3H, CH3). 
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13
C NMR(CDCl3): δ 138.9, 133.1, 132.4, 131.5, 129.2(2C), 126.9, 125.6, 125.5, 119.8, 94.2, 
87.4, 21.6. 
MS: 271(100), 191(84), 165(74), 82(59), exact mass calcd for C5H11Br m/z 270.0648, obsd m/z 
271.6. 
 
1-Bromo-2-[2-(3-toluyl)ethynyl]benzene 84 
Method A: 57 percent yield was observed using 3-ethynyltoluene (0.13 mL, 116 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).   
Method B: 54 percent yield was observed using 3-ethynyltoluene (0.13 mL, 116 mg, 1.2 mmol), 
purified by column chromatography (100% hexanes).   
TLC(100% Hexanes): 0.40. 
UV: λmax = 231 (є = 28), 290 (43), 309 (40).  
IR(CDCl3): 3058, 2923, 2855, 2249, 1601, 1487, 1467, 1433, 907, 732.  
1
H NMR(CDCl3): δ 7.61 (d, J= 7.5 Hz, 1H, Ar-H), 7.54 (d, J= 6.5 Hz, 1H, Ar-H), 7.40- 7.17 (m, 
6H, Ar-H), 2.36 (s, 3H, CH3).  
13
C NMR(CDCl3): δ 138.0, 133.2, 132.4, 132.2, 129.5, 129.3, 128.8, 128.3, 127.0, 125.6, 125.4, 
122.6, 94.1, 87.6, 21.3. 
MS: 272(95), 190(100), 165(97), 94(99), exact mass calcd for C5H11Br m/z 270.0648, obsd m/z 
272.2. 
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1-Bromo-2-[2-(3-fluorophenyl)ethynyl]benzene 85 
Method A: 56 percent yield was observed using 1-ethynyl-3-fluorobenzene (0.12 mL, 120 mg, 
1.2 mmol) and Pd(PPh3)4 (69 mg, 0.06 mmol), purified by column chromatography (100% 
hexanes).   
Method B: 11 percent yield was observed using 1-ethynyl-3-fluorobenzene (0.12 mL, 120 mg, 
1.2 mmol) and Pd(PPh3)4 (69 mg, 0.06 mmol), purified by column chromatography (100% 
hexanes).   
TLC(2:1, Ethyl Acetate:Hexanes): 0.42. 
UV: λmax = 285 (є = 92).  
IR(CDCl3): 3071, 2252, 1608, 15679, 1488, 1466, 1434, 908, 734. 
1
H NMR(CDCl3): δ 7.63 (d, J= 9.0 Hz, 1H, Ar-H), 7.56 (dd, J= 1.5 Hz, 1.5 Hz, 1H, Ar-H), 7.38-
7.28 (m, 4H, Ar-H), 7.21 (td, J= 1.5 Hz, 1H, Ar-H), 7.08 (tt, J=1 Hz, 1.5 Hz, 1 Hz, 1H, Ar-H). 
13
C NMR(CDCl3): δ 163.4, 161.5, 133.1, 130.2, 129.6, 129.5, 128.4, 127.6, 125.8, 125.0, 118.4, 
116.0, 92.5, 89.2.  
MS: 274(100), 194(80), 175(66), 97(55), exact mass calcd for C14H8FBr m/z 274.5487, obsd m/z 
274.0 
 
1-Bromo-2-[2-(3-pyridinyl)ethynyl]benzene 102 
Method A:  13 percent yield was observed using 3-ethynylpyyridine (132 mg, 1.2 mmol) and the 
reaction was run for 72 hours, purified by column chromatography (10% Ethyl Acetate/ 
hexanes).  
TLC(2:1, Ethyl Acetate:Hexanes): 0.39. 
UV: λmax = 282 (є =100), 328 (39).  
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IR(CDCl3): 3052, 2965, 2223, 1578, 1560, 1481, 1463, 1434, 1407, 1045, 1025, 908, 804, 754, 
732, 703, 646. 
1
H NMR(CDCl3): δ 8.82(s, 1H, Ar-H), 8.56(s, 1H, Ar-H), 7.82(d, J=8 Hz, 1H, Ar-H), 7.60(d, 
J=8 Hz, 1H, Ar-H), 7.54(dd, J=1.5 Hz, 1H, Ar-H), 7.29-7.25(m, 2H, Ar-H), 7.18(t, J=7.5 Hz, 1H, 
Ar-H) 
13
C NMR(CDCl3): δ 152.32, 148.96, 140.35, 138.53, 132.77, 132.58, 132.15, 129.94, 128.52, 
127.14, 123.04, 91.15, 90.36. 
MS: 256(100), 177(99), 152(92), 125(96), 99(92), 62(80), exact mass calcd for C13H8NBr m/z 
256.9846, obsd m/z 256.6. 
 
3-(2-Bromophenyl)-2-propynol pyrrole2-carboxylate 89 
Method A:  24% yield was observed using 64 (179 mg, 1.2 mmol) and the reaction was run for 
48 hours, purified by column chromatography (10% Ethyl Acetate/ hexanes).  
TLC(2:1, Ethyl Acetate:Hexanes): 0.54. 
UV: λmax = 262 (є = 19). 
IR(CDCl3): 3452, 3311, 2973, 2249, 1693, 1587, 1554, 1468, 1433, 1411, 1312, 1268, 1167, 
1130, 1080, 992, 909, 734, 649, 606. 
1
H NMR(CDCl3): δ 9.35(s, 1H, NH), 7.85(d, J=3 Hz, 1H, Ar-H), 7.67-7.45(m, 3H, Ar-H), 7.26-
7.15(m, 3H, Ar-H), 6.99(dd, J=7 Hz, 1H, Ar-H), 6.27(s, 1H, Ar-H), 5.14(s, 2H, CH2).  
13
C NMR(CDCl3): δ 160.17, 140.81, 133.75, 132.73, 132.41, 129.89, 129.70, 129.42, 128.48, 
128.36, 126.97, 87.78, 84.89, 52.51. 
MS: 289(29), 193(75), 94(100), mass calcd for C14H10O2NBr m/z 288.9958, obsd m/z 289. 
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3-(2-Bromophenyl)-2-propynol N-trimethylacetylpyrrole2-carboxylate 90 
Method A:  18 percent yield was observed using 88 (280 mg, 1.2 mmol) and the reaction was run 
for 72 hours, purified by column chromatography (10% Ethyl Acetate/ hexanes).  
TLC(2:1, Ethyl Acetate:Hexanes): 0.57. 
UV: λmax = 262 (є = 241).  
IR(CDCl3): 3455, 3319, 2978, 2252, 1701, 1555, 1436, 1310, 1160, 1107, 1054, 961, 908, 732, 
649. 
1
H NMR(CDCl3): δ 7.80(d, J=5.5 Hz, 1H, Ar-H), 7.56(t, J=6 Hz, 2H, Ar-H), 7.25-7.14(m, 2H, 
Ar-H), 7.00-7.93 (m, 1H, Ar-H), 6.28(d, J=36.5 Hz, 1H, Ar-H), 5.13(s, 2H, CH2), 1.25(s, 9H, 3 
CH3’s).  
13
C NMR(CDCl3): δ 172.86, 160.09, 140.14, 132.07, 131.90, 129.78, 129.31, 123.59, 123.54, 
116.16, 101.14, 98.82, 87.80, 84.79, 52.37, 44.68, 27.47, 26.67, 24.59. 
 
2-[2-(3-Pyridinyl)ethynyl]-1-[2-(trimethylsilyl)ethynyl]benzene 92 
(2-Bromophenylethynyl)trimethylsilane (0.213 mL, 253 mg, 1.0 mmol), Pd(PPh3)4 (23 
mg, 0.02 mmol) and CuI (7.6 mg, 0.04 mmol) were combined in a heavy walled reaction vessel 
with dry diisopropylamine (5 mL). 3-ethynylpyridine (132 mg, 1.2 mmol) was then added and 
the mixture was degassed for two minutes with N2 gas. The reaction vessel was tightly capped 
and heated for 72 hours at 130
o
C. The reaction was then filtered over Celite and washed with 
diethylether (10 mL x 3). The mixture was then washed with saturated NaHCO3 (10 mL) and the 
organic layer was dried with MgSO4. The solvent was removed in vacuo and the product purified 
by column chromatography (10% Ethyl Acetate/ hexanes). An 11 % yield was obtained as 
determined by GC.  
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TLC(100% Hexanes): 0.51. 
UV: λmax = 255 (є = 242), 297 (229). 
IR(CDCl3): 3061, 2960, 2899, 2224, 2158, 1563, 1484, 1442, 1407, 1250, 909, 873, 845, 734, 
646.  
1
H NMR(CDCl3): δ 8.80(d, J= 1 Hz, 1H, Ar-H), 8.55 (dd, J=1.5 Hz, 1H, Ar-H), 7.82 (dt, J=1.5 
Hz, 1, 1H, Ar-H), 7.53-7.51 (m, 2H, AR-H), 7.32-7.27(M, 3H, AR-H), 0.27-0.26 (M, 9H, TMS).  
13
C NMR(CDCl3): δ 152.32, 148.70, 138.42(2C), 132.36(2C), 131.80(2C), 128.42, 128.28, 
125.78, 125.26, 123.02, 120.48, 103.17, 99.04, 91.40, 89.796, 44.98(3C). 
MS: 275(100), 244(92), 261(86), 259(77), 217(56), exact mass calcd for C18H17NSi m/z 
276.1243, obsd m/z 275.3.  
ICP-AES: 0.1189ppm (traces of Pd) 
 
2-(2-Phenylethynyl)-1-[2-(3-pyridinyl)ethynyl]benzene 93 
80 (186 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 13% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.43. 
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UV: λmax = 275 (є = 34). 
IR(CDCl3): 3057, 2923, 2216, 2223, 1597, 1560, 1494, 1481, 1442, 1406, 1022, 755, 702, 690. 
1
H NMR(CDCl3): δ 8.82 (s, 1H, Ar-H), 8.55 (s, 1H, Ar-H), 7.82 (d, J= 8 Hz, 1H, AR-H), 7.58-
7.55 (m, 4H, Ar-H),  7.36-7.25 (m, 6H, Ar-H). 
13
C NMR(CDCl3): δ 152.21, 148.67, 138.48, 131.91(2C), 131.59(2C), 128.61, 128.57(2C), 
128.48(2C), 128.07, 125.97, 124.97, 123.11, 123.04, 93.85, 91.53, 89.93, 87.96.  
MS: 279(100), 277(74), 250(54), exact mass calcd for C21H13N m/z 279.1020, obsd m/z 279.1. 
ICP-AES: 0.0042ppm (traces of Pd) 
 
2-[2-(4-Aminophenyl)ethynyl]-1-[2-(3-pyridinyl)ethynyl]benzene 94 
81 (234 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 12% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.45. 
UV: λmax = 288 (є = 33), 307 (33), 328 (24). 
IR(CDCl3): 3333, 3056, 2964, 2253, 2212, 1606, 1515, 1481, 1436, 1260, 1181, 1119, 1024, 
723, 696, 644. 
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1
H NMR(CDCl3): δ 8.80 (s, 1H, Ar-H), 8.56 (s, 1H, Ar-H), 8.23(d, J=7.5 Hz, 1H, Ar-H), 7.61-
7.52 (m, 3H, Ar-H), 7.35-6.89 (m, 5H, Ar-H), 6.67(d, J=8 Hz, 1H, Ar-H), 3.72(s, 2H, NH2). 
13
C NMR(CDCl3): δ 152.29, 148.94, 13.60, 133.20, 131.69, 131.59, 129.96, 129.32, 129.27, 
128.45, 128.31, 127.14, 127.00, 122.08, 117.80, 115.33, 94.19, 91.75, 89.5, 88.76. 
ION TRAP MS(+Na): 316(100), 293(79), 127(58),exact mass calcd for C21H14N2 m/z 294.1167 
(+23=317), obsd m/z 316.6. 
 
2-[2-(3-Aminophenyl)ethynyl]-1-[2-(3-pyridinyl)ethynyl]benzene 95 
82 (234 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 14% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.32. 
UV: λmax = 230 (є = 780), 248 (621), 285 (875). 
IR(CDCl3): 3291, 3058, 2965, 2928, 2253, 2222, 1609, 1581, 1483, 1437, 1263, 1184, 1119, 
1025, 909, 723, 695, 541. 
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1
H NMR(CDCl3): δ 8.81(s, 1H, Ar-H), 8.58(d, J=4 Hz, 1H, Ar-H), 7.86 (dt, J=1.5 Hz, 1H, Ar-
H), 7.64-7.50 (m, 4H, Ar-H), 7.39-7.12(m, 4H, Ar-H), 6.64 (dt, J=2 Hz, 1H, Ar-H), 5.97 (s, 2H, 
NH2). 
13
C NMR(CDCl3): δ 152.28, 148.93, 138.56, 133.35, 132.95, 132.6, 132.55, 132.33, 129.95, 
128.69, 128.45, 128.25, 127.64, 127.14, 126.94, 125.67, 114.73, 94.73, 94.91, 91.13, 90.32, 
86.17. 
ION TRAP MS(+Na): 316(100), 293(32), 229(30), 127(37),exact mass calcd for C21H14N2 m/z 
294.1167 (+23=317), obsd m/z 316.6. 
 
2-[2-(3-Amino-N-trimethylacetylphenyl)ethynyl]-1-[2-(3-pyridinyl)ethynyl]benzene 100 
87 (257 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 68 (238 mg, 1.2 mmol) was added and the mixture was degassed for two 
minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 110
o
C. 
The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 9% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.21. 
UV: λmax = 252 (є = 37), 274 (38), 328 (27). 
IR(CDCl3): 3340, 3305, 3065, 2963, 2928, 2253, 2221, 1609, 1584, 1483, 1436, 1184, 1074, 
1025, 905, 908, 786, 765, 723, 734, 650, 473. 
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1
H NMR(CDCl3): δ 8.82 (s, 1H, Ar-H), 8.55 (s, 1H, Ar-H), 7.90 (s, 1H, Ar-H), 7.79 (d, J=3.5 
Hz, 1H, Ar-H), 7.56 (dd, J=4.5 Hz, 4H, Ar-H), 7.37-7.26 (m, 4H, Ar-H), 4.09 (s, 1H, N-H), 
1.27(s, 9H, 3CH3’s). 
13
C NMR(CDCl3): δ 176.66, 171.15, 152.31, 148.68, 138.29, 131.96, 131.88, 129.11, 128.59, 
128.16, 127.33, 125.98, 125.12, 123.78, 123.24, 122.96, 120.33, 93.49, 91.58, 90.07, 88.18, 
60.40, 31.60, 31.62, 27.61. 
ION TRAP MS(+Na): 425(57), 401(100), 341(36), 301(53),exact mass calcd for C26H22N2O m/z 
378.9732 (+23=401), obsd m/z 401.2. 
 
2-[2-(4-Amino-N-trimethylacetylphenyl)ethynyl]-1-[2-(3-pyridinyl)ethynyl]benzene 99 
86 (257 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 70 (238 mg, 1.2 mmol) was added and the mixture was degassed for two 
minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 110
o
C. 
The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 4% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.36. 
UV: λmax = 287 (є =46), 307 (41). 
IR(CDCl3): 3350, 3405, 3064, 2955, 2929, 2253, 2223, 1609, 1574, 1473, 1437, 1174, 1074, 
1025, 905, 908, 789, 768, 726, 734, 651, 473. 
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1
H NMR(CDCl3): δ 1.38(s, 1H, Ar-H), 8.57(d, J=4 Hz, 1H, Ar-H), 7.83(dd, J=8 Hz, 1H, Ar-H), 
7.63-7.49(m, 4H, Ar-H), 7.30-7.12(m, 5H, Ar-H), 4.09(s, 1H, NH), 1.25(s, 9H, 3 CH3’s).  
13
C NMR(CDCl3): δ 171.15, 152.27, 152.25, 148.94, 148.56, 138.61, 133.3, 132.59, 131.72, 
129.99, 128.85, 128.48, 127.17, 125.70, 124.73, 123.15, 122.53, 120.20, 92.70, 91.19, 90.32, 
60.40, 31.63, 22.69, 21.04. 
ION TRAP MS(+Na): 401(68), 379(100), 279(36), 123(46),exact mass calcd for C26H22N2O m/z 
378.9732 (+23=401), obsd m/z 401.2. 
 
1-[2-(3-Pyridinyl)ethynyl]-2-[2-(4-toluyl)ethynyl]benzene 96 
83 (243 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 2.5% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.48. 
UV: λmax = 232 (є =40), 276 (72).  
IR(CDCl3): 3028, 2922, 2855, 2215, 1716, 1561, 1510, 1483, 1407, 1023, 908, 816, 733, 703, 
646.  
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1
H NMR(CDCl3): δ 8.81 (d, J=1 Hz, 1H, Ar-H), 8.56 (d, J=5.5 Hz, 1H, Ar-H), 7.83 (dt, J= 2 Hz, 
1.5 Hz, 1H, Ar-H), 7.57 (dd, J= 2 Hz, 2H, Ar-H), 7.45 (d, J=7.5 Hz, 2H, Ar-H), 7.35-7.27 (m, 
3H, Ar-H), 7.16 (d, J=8 Hz, 2H, Ar-H), 2.37 (s, 3H, CH3). 
13
C NMR(CDCl3): δ 152.2, 148.8, 148.5, 138.8, 138.5, 133.3, 132.5, 131.9, 131.8, 131.5, 129.9, 
129.2, 128.5, 127.8, 127.1, 126.3, 124.9, 123.1, 94.1, 91.6, 89.8, 87.4. 
MS: 293(100), 292(48), 291(23), exact mass calcd for C22H15N m/z 293.1216, obsd m/z 293.2. 
 
1-[2-(3-Pyridinyl)ethynyl]-2-[2-(3-toluyl)ethynyl]benzene 97 
84 (243 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 12% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.47. 
UV: λmax = 274 (є = 40), 307 (32). 
IR(CDCl3): 3033, 2923, 2856, 2247, 2222, 1600, 1581, 1561, 1489, 1482, 1407, 1024, 948, 804, 
784, 757, 647. 
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1
H NMR(CDCl3): δ 8.82 (s, 1H, Ar-H), 8.56 (s, 1H, Ar-H), 7.85 (t, J= 8.5 Hz, 1H, Ar-H), 7.57 
(d, J=7.5 Hz, 2H, Ar-H), 7.38-7.22 (m, 6H, Ar-H), 7.16 (d, J= 7.5 Hz, 1H, Ar-H), 2.33 (s, 3H, 
CH3).  
13
C NMR(CDCl3): δ 152.23, 148.66, 138.48, 138.12, 133.34, 132.55, 132.24, 131.85, 131.82, 
129.52, 128.61, 128.37, 127.98, 127.13, 126.67, 125.00, 122.84,94.13, 91.61, 89.92, 87.67, 
21.25. 
MS: 293(100), 292(49), 291(24), exact mass calcd for C22H15N m/z 293.1216, obsd m/z 293.1. 
ICP-AES: 0.0066ppm (traces of Pd) 
 
2-[2-(3-Fluorophenyl)ethynyl]-1-[2-(3-pyridinyl)ethynyl]benzene 98 
85 (246 mg, 1.0 mmol) was dissolved in dry diisopropylamine (5 mL) in a heavy walled 
reaction vessel with a stir bar. Pd(PPh3)4 (48.5 mg, 0.04 mmol) was then added and stirred for 
ten minutes. CuI (26.6 mg, 0.14 mmol) was then added and allowed to stir for an additional 10 
minutes. Lastly, 3-ethynylpyridine (132 mg, 1.2 mmol) was added and the mixture was degassed 
for two minutes with N2 gas. The reaction vessel was tightly capped and heated for 72 hours at 
110
o
C. The reaction was then filtered over Celite and washed with diethyl ether (10 mL x 3). The 
mixture was then washed with saturated NaHCO3 (10 mL) and the organic layer was dried with 
MgSO4. The solvent was removed in vacuo and the product purified by column chromatography 
(10% Ethyl Acetate/ hexanes). A 25% yield of was obtained as determined by GC.  
TLC(2:1, Ethyl Acetate:Hexanes): 0.43. 
UV: λmax = 273 (є =63), 328 (69). 
IR(CDCl3): 3065, 2926, 2251, 2224, 1607, 1579, 1491, 1407, 1263, 1205, 1024, 908, 785, 731, 
649. 
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1
H NMR(CDCl3): δ 8.80(d, J=1 Hz, 1H, Ar-H), 8.56 (dd, J= 1 Hz, 2H, Ar-H), 7.82 (dt, J= 2 Hz, 
1.5 Hz, 1H, Ar-H), 7.57 (q, J= 4 Hz, 4.5 Hz, 2H, Ar-H), 7.35-7.22 (m, 5H, Ar-H), 7.07-7.03 (m, 
1H, Ar-H). 
13
C NMR(CDCl3): δ 163.38, 161.42, 152.20, 148.78, 138.45, 132.00, 130.12, 130.05, 128.61, 
128.43, 127.48, 127.46, 125.13, 124.92, 118.42, 118.24, 116.05, 92.41, 91.32, 90.06, 88.80. 
MS: 297(100), 296(67), 295(23), exact mass calcd for C21H12F m/z 296.1179, obsd m/z 297.1. 
 
4.2.2 Experimental for Chapter Three 
Cell culture 
Human alveolar type 11-like epithelial A549 cells (ATCC# CCL-185, ATCC ampule 
passage no. 80; American Type Culture Collection, Manassas, VA, USA) were maintained in 
Costar 0.2 μm vent cap cell culture flasks (Corning, Corning, NY, USA) with standard 
Dulbecco’s modified Eagle’s medium nutrient mixture F-12 Ham (Sigma-Aldrich, Oakville, ON, 
Canada) supplemented with 10% iron-fortified bovine calf serum (SAFC Biosciences, Lenexa, 
KS, USA), 2 mM l-glutamine (Gibco, Carlsbad, CA), and antibiotic/antimycotic (100 U/mL 
penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL amphotericin B; Gibco).  Cultures were 
incubated at 37ºC in a humidified atmosphere of 5 % CO2 in air and sub-cultured when 80% 
confluent.  Prior to plating, cell counts and viabilities were assessed using a Vi-Cell XR Cell 
Viability Analyzer (Beckman Coulter, Mississauga, ON, Canada).  Experiments were performed 
using serum-free media. 
H9c2(2-1) is a subclone of the original clonal cell line derived from embryonic BD1X rat 
heart tissue.    
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Cytotoxic Properties of Activated Enediynes - Cell Viability  
Before the cell testing could take place, approximately 10,000 A549 or H9c2 cells/ well 
were seeded into sterile flat-bottom 96-well plates (Corning, clear), and incubated for 24 hours in 
serum media. To determine the cytotoxicity of the UV active drugs, cells were tested as control, 
control and Tween 80, or enediyne -containing media (range 7-15 μM final concentration).  Each 
enediyne was first dissolved in 200µL of the surfactant Tween 80 (a mono-fatty acid ester of 
polyoxyethylene sorbitan) before being placed in the serum-free media. After 3 hours and 50 
minutes of pre-incubation of the A549 or H9c2 cells with the enediynes, the drugs were activated 
with a 10 min or 6.5 min exposure to 302nm UV light, respectively (UVB Transilluminator, 8 
watts, 115 V, ~60 Hz and 0.7 Amps, Toronto, Canada) and then incubated for a further 16 hours, 
for a 24 hour total incubation period (including 4 hours of MTT).  Control cells were exposed to 
the enediynes alone or UV light alone.  
The MTT (method of transcriptional and translational) assay was used to assess cell 
death. This test works by standard colorimetric assay (an assay which measures changes in color) 
and measures the activity of enzymes that reduce MTT to formazan, giving a purple color. It can 
also be used to determine cytotoxicity of potential medicinal agents and other toxic materials, 
since those agents would result in cell toxicity and therefore metabolic dysfunction and 
decreased performance in the assay. Yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a tetrazole) was used due to its ability to reduce to purple 
formazan in living cells. After the cells were incubated for the further 16 hours, culture media 
(150 μL) was replaced with fresh media containing 10 % yellow MTT (Thiazolyl Blue 
Tetrazolium Bromide; Sigma-Aldrich) reagent and cells were incubated under standard 
conditions for an additional 4 hours.  The culture media were aspirated and 50 μL 
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dimethylsulfoxide was added per well to solubilize the formazan crystals.  Following agitation, 
absorbance was measured spectrophotometrically at a wavelength of 570 nm (650 nm 
background correction wavelength) using a PowerWave XS Microplate Spectrophotometer 
(BioTek, Winooski, VT, USA).  Viabilities of challenged cells were assessed relative to control 
cells. 
 
4.2.3 Experimental for Chapter Four 
 All of the standard calibration curves were prepared by Dr. Christine Gottardo except for 
5-phenyl-2-furaldehyde and 2-furaldehyde. All of the compounds presented in Chapter Four 
have been previously characterized and found in the literature except for the following:
45-47,56 
 
General Procedures for Direct Arylation: 
Method A:  Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol) and Pd-catalyst (0.05 
mmol) were combined in a vial containing dry benzene (2.7 mL), sealed and heated to 110
o
C for 
five hours.  The mixture was cooled and filtered over Celite using CH2Cl2.  The organic layer 
was removed in vacuo.  GC samples were prepared by adding CH2Cl2 (5.0 mL) and the internal 
standard, 1,2-dichlorobenzene (7.6 µL). 
 
Method B:  Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), benzoquinone (2.0 
mmol, 0.216 g), pivaloyl acid (6.0 mmol, 0.613 g)  and Pd-catalyst (0.05 mmol) were combined 
in a vial containing dry benzene (2.7 mL), sealed and heated to 110
o
C for five hours.  The 
mixture was cooled and filtered over Celite using CH2Cl2.  The organic layer was removed in 
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vacuo.  GC samples were prepared by adding CH2Cl2 (5.0 mL) and the internal standard, 1,2-
dichlorobenzene (7.6 µL). 
 
Method C:  Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), CsOPiv (0.4 mmol, 
0.094 g),  4-methyl-3-nitropyridine (0.1 mmol, 0.014 g), pivaloyl acid (6.0 mmol,0.613 g)  and 
Pd-catalyst (0.05 mmol) were combined in a vial containing dry benzene (2.7 mL), sealed and 
heated to 110
o
C for five hours.  The mixture was cooled and filtered over Celite using CH2Cl2.  
The organic layer was removed in vacuo.  GC samples were prepared by adding CH2Cl2 (5.0 
mL) and the internal standard, 1,2-dichlorobenzene (7.6 µL). 
 
Method D: Heteroaromatic compound (1.0 mmol), oxidant (6.0 mmol), benzoquinone (2.0 
mmol, 216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-catalyst (0.05 mmol) were combined 
in a vial containing dry benzene (2.7 mL), sealed and heated to 110
o
C for five hours. The 
mixture was cooled and filtered over Celite using CH2Cl2.  The organic layer was removed in 
vacuo.  GC samples were prepared by adding CH2Cl2 (5.0 mL) and the internal standard, 1,2-
dichlorobenzene (7.6 µL). 
 
Method E: Heteroaromatic compound (1.0 mmol), oxidant (1.5 mmol), benzoquinone (2.0 mmol, 
216 mg), pivaloyl acid (6.0 mmol, 613 mg)  and Pd-catalyst (0.05 mmol) were combined in a 
vial containing dry benzene (2.7 mL), sealed and heated to 110
o
C for five hours. The mixture 
was cooled and filtered over Celite using CH2Cl2.  The organic layer was removed in vacuo.  GC 
samples were prepared by adding CH2Cl2 (5.0 mL) and the internal standard, 1,2-
dichlorobenzene (7.6 µL). 
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General Procedure for Photochemical Direct Arylation: 
Method F: Heteroaromatic compound (1.0 mmol), oxidant (3.0 mmol), benzoquinone (2.0 mmol, 
0.216 g), pivaloyl acid (6.0 mmol, 0.613 g) and Pd-catalyst (0.05 mmol) were combined in a 
quartz tube containing dry benzene (2.7 mL). The system was purged with Nitrogen for 2 
minutes, sealed with a septum and irradiated with UV light for 5 hours.  The mixture was cooled 
and filtered over Celite using CH2Cl2.  The organic layer was removed in vacuo.  GC samples 
were prepared by adding CH2Cl2 (5.0 mL) and the internal standard, 1,2-dichlorobenzene (7.6 
µL). 
 
GC Analysis: 
GC analyses were performed on an Agilent 6850 using an Agilent DB-5HT, 30m long, 0.25mm 
diameter, 0.10µm film thickness, with temperature limits of -20° to 300°C column.  Calibration 
curves were constructed using 1,2-dichlorobenzene as an internal standard and a pure sample of 
the phenyl substituted heteroaromatic compound obtained either directly from Sigma-Aldrich (5-
phenyl-2-furaldehyde) or synthesized through a Suzuki coupling from the correctly substituted 
heteroaromatic boronic acid ester and iodobenzene. 
 
 
2-Phenylfuran
45,46
:  
2-Furanylboronic acid (1.05 mmol, 0.117 g), iodobenzene (1.0 mmol, 0.204 g, 0.11 mL), 
Pd(OAc)2 (0.02 mmol, 0.005 g) and K2CO3 (2.5 mmol, 0.345 g) were combined in acetone / 
water (2.0 mL/ 2.5 mL) and placed in a vial.  The vial was heated for 45 minutes at 65 
o
C.  The 
cooled solution was extracted with diethyl ether (4 x 10 mL). The combined organic extracts 
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were washed with water (10 mL), dried and removed in vacuo.  The residue was purified by 
MPLC, eluting with hexanes (100%).  The reaction yielded 0.075 g (36%) of a white solid.
   
1
H NMR (500 MHz, CDCl3): δ 6.47 (dd, J=2.4, 1.6 Hz, 1H), 6.65 (d, J=2.8 Hz, 1H), 7.24 (d, 
J=6.8 Hz, 1H), 7.38 (t, J=6.4 Hz, 2H), 7.47 (d, J=1.2 Hz, 1H), 7.67(d, J=5.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3): δ106.5, 111.4, 121.2, 122.7, 124.2, 127.4, 144.9, 153.7.   
MS (EI, 70eV): m/z (%):  115.1 (98), 144.1 (100) [M
+
]. Calcd mass: 145.13. 
 
2-methyl-5-phenylfuran
47
:  
5-Methylfuranyl-2-boronic acid pinacol ester (1.1 mmol, 0.229 g), iodobenzene (1.0 mmol, 
0.204 g, 0.11 mL), K2CO3 (2.5 mmol, 0.345 g), Pd(OAc)2 (0.02 mmol, 0.005 g) and 
tetrabutylammonium bromide (1.0 mmol, 0.322 g) were combined in deionized water (2.0 mL) 
and stirred at room temperature for five hours.   The reaction mixture was diluted with water 
(5mL) and extracted with EtOAc (4 x 10 mL).  The combined organic layers were stirred over 
charcoal (0.75 g) for 30 minutes and sodium sulfate was added.  The dried organic layer was 
filtered and the excess solvent removed in vacuo.  The residue was purified by MPLC, eluting 
with hexanes (100%).  The reaction yielded 0.098 g (62%) of a white solid.  
 
1
H NMR (500 MHz, CDCl3): δ 2.43 (s, 3H), 6.11 (d, J=3.5 Hz, 1H), 6.58 (d. J=3.5 Hz, 1H), 7.36 
(t, J=8.0 Hz, 1H), 7.45 (D, J=8.1 Hz, 2H), 7.71(d, J=8.0 Hz, 2H). 
13
C NMR (125 MHz, CDCl3): δ 105.8, 108.1, 123.8, 126.4, 128.8, 131.7, 149.8, 152.0. 
MS (EI, 70ev) m/z (%):115.1 (35), 157.1 (70%), 158.1 (100) [M
+
]. Calcd mass: 158.07. 
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APPENDIX I 
 
The following tables correspond to the values obtained for the A549 cells treated with 
ultraviolet light. The absorbances were measured spectrophotometrically at a wavelength of 
490nm (650 nm back ground correction wavelength) using a PowerWave XS Microplate 
Spectrophotometer (BioTek, Winooski, VT, USA). 
 
The following tables correspond to the values obtained for the A549 cells not treated with 
ultraviolet light. The absorbances were measured spectrophotometrically at a wavelength of 
490nm (650 nm back ground correction wavelength) using a PowerWave XS Microplate 
Spectrophotometer (BioTek, Winooski, VT, USA). 
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APPENDIX II 
 
The following tables correspond to the values obtained for the H9c2 cells treated with 
ultraviolet light. The absorbances were measured spectrophotometrically at a wavelength of 
490nm (650 nm back ground correction wavelength) using a PowerWave XS Microplate 
Spectrophotometer (BioTek, Winooski, VT, USA). 
 
The following tables correspond to the values obtained for the H9c2 cells not treated with 
ultraviolet light. The absorbances were measured spectrophotometrically at a wavelength of 
490nm (650 nm back ground correction wavelength) using a PowerWave XS Microplate 
Spectrophotometer (BioTek, Winooski, VT, USA). 
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